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Abstract
Deproteinized	   bovine	   bone	   (DBB)	   is 	   a	   bone	   gra@	   highly	   used	   in	   den7stry	   in	   bone	  
regenera7on	  and	  alveolar	   socket	  preserva7on	   techniques.	  Although	  there	  is 	  a 	  scien7ﬁc	  
consensus 	  on	  the	  clinical 	  beneﬁt	  of	  this 	  biomaterial,	  and	  several 	  in	  vitro	  studies 	  described	  
its 	  biologic	  eﬀect	  on	  osteoblasts,	  in	  vivo	  analyses	  inves7ga7ng	  its 	  eﬀect	  on	  bone	  dynamics	  
on	  human	  are	  lacking.	  For	  this 	  purpose	  20	  pa7ents 	  needing	  tooth	  extrac7on	  and	  implant	  
placement	  were 	  selected	  and	  randomized	  in	  test	  (alveolar	  socket	  preserva7on	  with	  DBB)	  
and	   control	   (spontaneous	   healing).	   Bone 	   specimens 	   were	   collected	   during	   tooth	  
extrac7on	  (T0)	  and,	  at	  5	  months,	  during	  implant	  placement	  (T1).	  The	  collected	  samples	  
were	  processed	  for	  histologic	  and	  immunohistological 	  analyses 	  to	  reveal 	  the 	  presence 	  of	  
posi7ve	  (BMP-­‐2,	  BMP-­‐7,	  ALP)	  and	  nega7ve	  (Il-­‐6,	  TNF-­‐α)	  markers 	  of	  bone	  remodeling.	  The	  
sec7ons 	  were 	  then	  micro-­‐photographed,	  quan7ﬁca7on	  was 	  done	  and	  sta7s7cal 	  analyses	  
were	  performed	  to	  compare 	  T0	  and	  T1	  in	  both	  groups 	  and	  T1	  test	  group	  versus 	  T1	  control	  
group.	  	  The	  obtained	  results 	  showed	  higher	  expression	  of	  BMP-­‐2,	  BMP-­‐7	  and	  IL-­‐6	  at	  T1	  in	  
both	   groups	   (p<0.05),	   lower	   expression	   of	   ALP	   in	   both	   (p<0.05)	   at	   T1	   and	   higher	  
expression	  of	  TNF-­‐α	  only	   in	  test	  group	  (p<0.05)	  while	  in	  control 	  group	  it	  remained	  stable	  
during	  7me.	  When	  comparing	  T1	  markers	  expression	  in	  control	  and	  test	  groups,	  a 	  higher	  
expression	  of	  BMP-­‐2	  (p<0.05)	  and	  lower	  expression	  of	  TNF-­‐α	  (p<0.05)	  were	  found	  in	  the	  
ﬁrst	   one.	  These	  results 	  are 	  in	  concordance 	  with	  the	  previous 	  in	  vitro	  studies 	  and	  show	  
that	  DBB	  is 	  able 	  to	  maintain	  bone 	  remodeling	  in	  ac7ve	  phases.	  As 	  a	  maaer	  of	   fact	   at	  5	  
months	   a	   higher	   expression	   of	   the	   posi7ve	   markers 	   (BMP-­‐2,	   BMP-­‐7)	   was 	   no7ced	  
compared	   to	  T0,	   but	   the 	  presence	  of	   DBB	   resulted	   in	   lower	   expression	  of	   BMP-­‐2	   and	  
higher	   expression	   of	   inﬂammatory	   factor	   (TNF-­‐α)	   when	   comparing	   to	   spontaneous	  
healing	  at	  the	  7me	  of	  the	  implant	  placement.	  
For	   these	   reasons	   the	   use	   of	   DBB	   is 	  suggested	  when	   clinical 	  needs	   lead	   to	   a	   precise	  
indica7on	   of	   alveolar	   socket	   preserva7on	   with	   biomaterial,	   while,	   if	   not	   clinically	  




1.1	  	   Bone	  Morphology
Bone	   is 	  a 	  specialized	   connec7ve	  7ssue	   and	  provides 	  diﬀerent	   func7ons	  for	   the	  en7re	  
body.	  It	  protects 	  inner	  structure	  from	  external 	  injuries 	  and	  it	  gives	  func7on	  and	  reten7on	  
to	  tooth.	  Bone	  may	   be	  deﬁned,	   from	   a	  morphological 	  point	   of	  view,	   as 	  Alveolar	   Bone,	  
Cor-cal	  Bone	  and	  Woven	  Bone.	  Alveolar	  bone	  origins	  from	  dental 	  follicle 	  and	  cooperates	  
with	  periodontal 	  ligament	  and	  cementum	  in	  providing	  tooth	  aaachment	  system.	  Alveolar	  
bone	  is 	  also	  deﬁned	  as 	  “lamina 	  dura”	  and	  it	   is 	  visible	  in	  radiography	   as 	  a	  thin	  line	  with	  
high	  radiopacity;	   Sharpey	  ﬁbers,	  coming	  from	  cementum	  in	  the 	  direc7on	  of	  the 	  alveolar	  
bone,	  take	  inser7on	  through	  lamina 	  dura.	  Cor-cal	  Bone	  is 	  composed	  by	  lamellar	  bone	  and	  
it	  deﬁnes 	  buccal 	  and	  lingual/palatal	  borders	  of	  alveolar	  process.	  Cor7cal 	  width	  variates:	  it	  
is 	  higher	  in	  palatal 	  side 	  of	  upper	  jaw	  or	   in	  ves7bular	  sides	  of	  anterior	  mandibula,	  while	  it	  
is 	  thinner	  in	  the	  ves7bular	  side	  of	  maxilla 	  or	  in	  the	  lingual 	  plates 	  of	  lower	  molars.	  Cor7cal	  
and	   alveolar	   bone	   are 	   in	   con7nuity	   in	   the	  most	   coronal	   side 	  of	   alveolar	   process,	   in	  
interdental 	  spaces.	  Woven	   bone 	  is 	  the	  por7on	   of	   bone	   included	   between	   cor7cal 	  and	  
alveolar	   bone,	   it	   is 	   also	   called	   trabecular	   bone 	   because	   of	   its 	   three-­‐dimensional	  
disposi7on	  of	  trabeculae.
Bone	   7ssue	   is 	   a	   connec7ve	   specialized	   7ssues 	   characterized	   by	   the	   presence	   of	  
mineralized	  matrix	   which	  provides 	  protec7on	  from	  external	  injuries 	  and	  collaborates 	  in	  
systemic	   homeostasis 	  as 	  mineral 	  reserve.	   It	   is 	  characterized	  by	   an	   extracellular	  matrix	  
composed	   of	  proteins,	   specialized	  cells	  and	  amorphous	  substance.	   Extracellular	  matrix	  
represents 	   the	  main	   frac7on	   of	   bone 	  7ssue,	   while 	  water	   is 	  the 	  remaining	   10%.	   Bone	  
matrix	   is 	  composed	  by	  organic	   components	  (35%)	  and	  inorganic	  components 	  (60%).	  The	  
organic	   part	   is	   mainly	   represented	   by	   type	   I	   collagen	   ﬁbers	   (90%)	   and	   others 	   non	  
collagenic	   proteins 	  (osteopon7n,	   osteocalcin,	   etc...),	   plus 	  growth	   factors,	   the	   inorganic	  
parts	   is 	   composed	   of	   calcium	   phosphate 	   in 	   diﬀerent	   forms 	   (hydroxyapa7te,	   calcium	  
carbonate	   and	   others 	   ions).	   	   The 	   remaining	   part	   of	   bone 	   7ssue	   is 	   made	   of	   cell,	   in	  
par7cular	  osteoprogenitor	  cells,	  osteoblasts,	  osteocytes 	  and	  osteoclasts.	  Osteoprogenitor	  
cells 	  are 	  unindiﬀeren7ated	   mesenchymal	   cells 	   able	   to	   diﬀeren7ate	   in	   bone	   line	   cells	  
under	   the	   s7mulus 	   of	   osteoinduc7ve	   growth	   factors.	   They	   are	   mainly	   located	   in	  
periosteum	   and	   endosteum	   and	   they	   are 	   ac7vated	   during	   bone	   remodeling	   process.	  
Osteoblasts 	  are 	  mononuclear	  cells 	  able	  to	  produce	  extracellular	  bone	  matrix,	  also	  deﬁned	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as 	  osteoid	  when	  it	  is 	  not	  completely	  mature 	  and	  mineralized,	  and	  they	  work,	  during	  bone	  
deposi7on,	  in	  sort	  of	  cells 	  clusters.	  They	  derive	  from	  mesenchymal 	  stem	  cells 	  s7mulated	  
by	  growth	  factors	  and	  they	  may	  be	  in	  ac7vate 	  or	  inac7ve	  form,	  they	  are 	  structural 	  part	  of	  
the	  bone.	  Osteocytes	  are	  mature 	  osteoblast	  cells 	  which	  remain	  embedded	  in	  bone 	  matrix	  
as 	   inac7ve	   cells,	   they	   are	   in 	   contact	   with	   other	   bone	   cells 	   trough	   small 	   canaliculus	  
containing	   cytoplasmic	   extensions.	   Bone	   canals 	   are 	   essen7al 	   for	   bone	   dynamic	   life,	  
oxygen	  and	  various 	  anabolic	  or	  catabolic	  product	  ﬂows 	  through	  the 	  canaliculi.	  Osteocytes	  
are 	  not	  yet	  able	  to	  produce	  bone 	  matrix,	  but	  they	  regulate 	  calcium	  homeostasis	  and	  play	  
their	   role	   as	   bone 	   mechanical 	   receptors.	   Osteoclasts 	   are	   mul7nucleated	   giant	   cells	  
involved	  in	  bone	  resorp7on,	  they	  derive	  from	  hematopoie7c	  stem	  cells 	  under	  osteoclast	  
inducing	  cytokines	  s7mulus.	   Osteoclasts 	  are	  organized	  in	  pits 	  called	  Howship’s 	  Lacunae	  
and	  contain	  vesicles 	  and	  vacuoles 	  with	  proteoly7c	  enzymes 	  able 	  to	  degrade	  bone.	  From	  a	  
histologic	   point	  of	   view	  alveolar	   bone	  can	  be	  divided	   in	  compact	   and	   spongious 	  bone.	  
Osteon	  or	   Havers 	  system	  is	  the	  func7onal 	  unit	   of	  cor7cal	  bone;	   it	   is 	  based	  on	  a 	  central	  
canal 	  (Havers 	  canal)	   containing	   nerves,	   blood	   vessels,	   surrounded	  by	   concentric	   bone	  
lamellae.	   The	  newly	   formed	   lamellae 	  are	  situated	   in	   the	  central 	  part	   of	   the 	  Haversian	  
system,	   while	  older	   lamellae	   are	  founded	   in	   the 	  external 	  por7on	  of	   the	   cylinder.	   Free	  
spaces 	  between	  diﬀerent	  osteons 	  are	  ﬁlled	  with	  inters77al	  lamellae	  and	  perfora7ng	  holes	  
(Volkmann’s 	  canals)	  that	  are 	  able 	  to	  interconnect	  osteons.	  Osteocytes 	  are	  limited	  in	  bone	  
lacunae	   situated	   in	   inter-­‐lamellar	   spaces.	   Osteons 	   spacial 	   orienta7on	   is 	   guided	   by	  
func7onal	  and	  mechanical	  bone	  loading.
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1.2	  	   Bone	  Physiology	  
Bone	  is	  a 	  dynamic	  system	  and	  it	  varies 	  its 	  anatomical 	  shape	  in	  response	  to	  physiological,	  
pathological 	  and	  mechanical	  inﬂuence.	   Bone	  remodeling	   is	  a	  physiological	  process 	  that	  
allows 	  to	  con7nuously	  renew	  7ssue	  and	  to	  maintain	  systemic	  mineral	  homeostasis.	  During	  
remodeling	   process 	   old	   bone	   is	   reabsorbed,	   replaced	   with	   bone	   matrix	   that	   will	   go	  
through	   mineraliza7on	   process 	   and	   will	   consequently	   form	   new	   mineralized	   bone.	  
Diﬀerent	  species 	  of	  cells 	  are	  involved	  in	  bone 	  remodeling,	  in	  a	  complex	  balance	  between	  
neo-­‐apposi7on	   work	   realized	   by	   osteoblasts 	   and	   osteoclasts 	   resorp7on.	   Coopera7on	  
between	  osteoblasts 	  and	  osteoclasts 	  can	  be 	  seen	  in	  bone	  mul7cellular	   units 	  which	  are	  
composed	  by	  a 	  line	  of	  osteoclasts 	  in	  the	  resorp7on	  por7on	  and	  a	  line 	  of	  osteoblasts 	  on	  
the	  bone	  matrix	   forma7on	   front.	   The	   remodeling	   process 	  consists 	  of	   diﬀerent	   phases:	  
resorp7on,	  reversal 	  and	  forma7on.	   Resorp7on	  is 	  acted	  by	   osteoclasts,	  mul7nuclear	  cells	  
promo7ng	  bone	  demineraliza7on	  and	  resorp7on.	   The	  reversal 	  phase	  is	  the	  7me	  in	  bone	  
remodeling	   when	   mononuclear	   cells 	   migrate	   on	   bone	   surface	   and	   set	   the	   right	  
environment	   for	  new	  bone	  crea7on	  by	   osteoclast.	  Mononuclear	   cells 	  produce	  signaling	  
proteins 	   that	   are	   able	   to	   s7mulate	   osteoblast	   migra7on	   and	   diﬀeren7a7on.	   In	   the	  
forma7on	  phase 	  the	  osteoblasts	  produce 	  new	  bone	  matrix	  un7l 	  new	  bone 	  is	  formed	  in	  
order	  to	  subs7tute	  the 	  quote	  lost	  in	  resorp7on	  phase.	   	  Resorp7on	  stage	  takes 	  usually	  2	  
weeks,	   while	   reversal 	  phase	   is 	   4	   weeks	   and	   bone	   forma7on	   includes 	  the	   further	   4-­‐6	  
months.	   This 	  7ming	   is	   important	   in	  our	   research	   protocol,	   we	  decided	   to	  verify	   bone	  
remodeling	  at	  6	  months 	  from	  the	  extrac7on	  phase 	  that	  coincides	  with	  the	  star7ng	  point	  
of	   resorp7on.	   At	   6	   months 	  we 	   are	   expec7ng	   to	   analyze 	   the	   pa7ents’	   bone 	   in	   bone	  
forma7on	  phase	  (Hadjidakis	  et	  al.	  2006,	  Clarke	  et	  al.	  2008,	  Dunstan	  et	  al.	  2007).
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1.3	  Morphogene.c	  proteins	  and	  cytokines.	  
Several	  signaling	  molecules 	  are	  involved	  in	  bone 	  remodeling	  process,	  they	  are	  able	  to	  up-­‐
regulate	   or	   down-­‐regulate 	   bone	   process,	   balancing	   resorp7on	   eﬀects 	   and	   new	   bone	  
forma7on.	  These	  molecules 	  are	  of	  fundamental 	  importance	  in	  our	  research,	  because	  they	  
can	   lead	   us	   to	   describe 	  how	   bone	   subs7tutes 	   can	   inﬂuence	   bone	   physiology.	   	   Both	  
systemic	  signaling	  and	  local 	  factors 	  are 	  able	  to	  inﬂuence	  bone	  dynamics,	  but,	   in	  order	  to	  
beaer	  understand	  the	  series	  of	  the	  events 	  involving	  bone 	  neoforma7on	  in	  post	  extrac7on	  
alveolar	   socket,	   it	   is 	  more	  useful 	   to	   describe 	   in	  detail 	   local	   factors 	  as 	  morphogene7c	  
proteins 	   and	   cytokines.	   Furthermore	   local 	   factors 	   are 	   mainly	   responsible	   for	   bone	  
remodeling	   a@er	   small 	  local 	  trauma	  and	  inser7on	  of	  bone	  subs7tute	   like	  what	  we	  are	  
trying	  to	  describe 	  in	  the 	  explained	  protocol.	   	  Both	  morphogene7c	  proteins	  and	  cytokines	  
are 	  molecules 	  able	  to	  regulate	  ac7va7on,	  migra7on	  and	  prolifera7on	  of	  bone	  cells.	  They	  
func7on	  as 	  signaling	  molecules 	  and	  ac7vate 	  target	  cells 	  when	  bind	  to	  speciﬁc	  membrane	  
receptors.	  A@er	  reaching	  chemical 	  contact	  with	  receptors,	  these	  factors 	  lead	  to	  a	  series	  of	  
intracellular	  signaling	  processes 	  ending	  in	  the	  ac7va7on	  of	  speciﬁc	  genes,	  that	  can	  modify	  
cells 	  phenotype 	  and,	  consequently,	  ac7vity.	  The 	  signaling	  molecules 	  are	  usually	  classiﬁed	  
through	  their	  origin	  or	  in	  reference	  with	  target	  cells	  (Hollinger	  et	  al.	  2011).
Proteins:
-­‐ TGF-­‐β:	  transforming	  growth	  factors 	  β	  are	  a	  big	  family	  of	  proteins 	  that	  contribute	  to	  cells	  
diﬀeren7a7on	   and	   prolifera7on.	   They	   are	   secreted	   by	   platelets,	   osteoblasts 	   and	  
chondroblasts.	  At	  the	  beginning	  they	  are	  inac7ve	  but,	  a@er	  proteoly7c	  scission	  they	  are	  
divided	  in	  latent	  parts 	  and	  ac7ve	  components:	  the 	  ac7ve 	  growth	  factor.	  TGF-­‐β	  binds	  two	  
speciﬁc	  surface	  cell 	  receptors 	  and	  promotes 	  intracellular	  signaling	  of	  SMAD	  proteins 	  and,	  
furthermore,	   TGF-­‐β	   promotes 	   Runx2	   expression,	   a	   key	   factor	   for	   osteoblasts	  
diﬀeren7a7on.	  All 	  these 	  factors	  are	  able	  to	  promote	  new	  bone 	  forma7on	  (Hughes 	  et	  al.	  
2006).
-­‐	  BMP:	   bone 	  morphogene7c	   proteins 	  are	  members	  of	   the 	  family	   of	   TGF-­‐β.	  More	  than	  
forty	   BMP	   are	   produced	   by	   our	   body,	   but	   those	  which	   are	  mainly	   involved	   in	   bone	  
remodeling	   are 	  BMP-­‐2,	   BMP-­‐4,	   BMP-­‐5,	   BMP-­‐6	   and	   BMP-­‐7.	   They	   act	   by	   binding	   bone	  
morphogene7c	  protein	   receptor	   type	  1	  and	  2,	   that	   are 	  expressed	  on	  cell 	  surface,	   and,	  
a@er	  binding,	  they	  s7mulate 	  intracellular	  signaling	  by	  SMAD	  receptor	  (in	  par7cular	  SMAD	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1,	   4,	   5,	   8),	   leading	   to	   intranuclear	   genic	   expression	   that	   ends 	   into	   osteocalcine	   and	  
alkaline	  phosphatases 	  produc7on.	   It	  can	  be	  aﬃrmed	  that	   BMP	   s7mulates	  mesenchimal	  
bone	  progenitor	  cells 	  diﬀeren7a7on	  through	  osteoblas7c	  phenotypes,	  inducing	  new	  bone	  
forma7on.	  
	  
-­‐	  IGF:	  insulin	  like	  growth	  factor	  are	  polypep7des 	  with	  amino	  acid	  sec7on	  similar	  to	  insulin	  
and	  are	  available	  in	  two	  forms:	   IGF-­‐1	   and	  IGF-­‐2	  binding	  to	  six	  diﬀerent	   ligand	  proteins.	  
IGF-­‐1	   is 	  strongly	   connected	  to	  bone	  metabolism	  process,	  it	   is 	  produced	  by	   the	  liver	  and	  
binds 	   to	   IGFR1	   receptor;	   when	   they	   are 	   bound	   they	   promote	   intracellular	   signaling	  
inci7ng	   prolifera7on	   and	   diﬀeren7a7on	   of	   pre-­‐osteoblas7c	   cells 	   and	   increase	   the	  
produc7on	  of	  Runx2,	  type	  I	  collagen	  and	  ALP	  (Hollinger	  et	  al.	  2011).
-­‐	  PDGF:	   platelet	  derived	  growth	  factors	  is	  a 	  family	   of	  four	  proteins	  (PDGF-­‐A,	  B,	  C,	  D)	  and	  
they	  act	  their	  roles 	  a@er	  binding	  to	  two	  speciﬁc	  cell 	  receptors:	  PDGFRα	  and	  PDGFRβ.	  The	  
most	   common	  formula 	  of	  PDGF	  is	  PDGF-­‐BB,	   it	  binds 	  to	  both	  surface	  receptors 	  and	  a@er	  
binding,	  it	  promotes	  phospho-­‐kinase 	  and	  tyrosine	  kinase 	  ac7vity	  inside	  cells.	  PDGF	  signal	  
promotes	  mesenchymal	  cells 	  migra7on	  and	  prolifera7on,	   but	   it	   is 	  not	   clear	   if	   it	   has 	  a	  
direct	  eﬀect	  on	  bone	  forma7on	  as	  osteoinduc7ve	  factor	  (Hughes	  et	  al.	  2006).
-­‐	  VEGF	  :	  vascular	  endothelial	  growth	  factors 	  are	  parts 	  of	  a 	  big	  family	   including	  4	  diﬀerent	  
forms 	  (VEGF-­‐A,	  B,	  C,	  D).	  They	  are	  all 	  produced	  by	  osteoblasts,	  chondroblast	  and	  platelets	  
and	  transmit	  signals 	  through	  3	  diﬀerent	  membrane	  receptors.	  VEGF-­‐A	   is 	  able 	  to	  induce	  
new	  vessels 	  forma7on	  in	  early	  phase 	  of	  healing	  and	  to	  promote	  new	  vessel 	  organiza7on	  
in	  later	  phases.	  It	  is 	  involved	  also	  in	  bone 	  remodeling	  process,	  it	   is 	  responsible 	  of	  oxygen	  
and	  nutrient	   factors 	  carrying	   in	   the 	  cloth,	   that	   	   are 	  fundamental 	  actors 	  for	   new	  bone	  
forma7on.	  It	  does	  not	  have 	  any	  eﬀects 	  on	  osteoblast	  promo7on	  and	  diﬀeren7a7on,	  but,	  
when	  osteoblasts 	  are	  s7ll	   in	   site,	   it	  helps	  them	  by	   s7mula7ng	   other	   osteogenic	   factors	  
releasing	  (Hollinger	  et	  al.	  2011).
-­‐	  FGF:	  	  ﬁbroblasts 	  growth	  factors	  are 	  a	  superfamily	  of	  23	  correlated	  proteins,	  but	  the 	  most	  
known	  proteins	  are	  called	  FGF1	  and	  FGF2,	  they	  are	  involved	  in	  osteoblasts	  promo7on	  and	  
angiogenesis.	  Moreover,	   FGF9	   collaborates 	  with	  FGF2	   in	  s7mula7ng	  mature 	  osteoblasts	  
and	  for	  this	  reason	  are	  highly	  expressed	  during	  fractures	  repairing	  processes.
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Cytokines	  are	  molecules 	  playing	  a 	  fundamental 	  role	  during	  inﬂammatory	   events,	  able	  to	  
modulate 	  immunity	  response,	  but	  some	  cytokine	  may	  be	  also	  classiﬁed	  as 	  growth	  factor	  
because	  they	  are	  able	  to	  s7mulate	  cells	  prolifera7on.	  
The	  cytokines 	  that	  are	  mainly	   involved	  in	  bone 	  cells	  diﬀeren7a7on	  and	  bone	  metabolism	  
are:	  	  
-­‐	   RANK	   /	   RANK-­‐l:	   Rank	   is	   a	   cytokine	   that	   binds	   its	   speciﬁc	   membrane	   receptor	   called	   RANK-­‐l	  
(RANK-­‐ligand).	  When	  binding	  is 	  completed,	  it	  starts	  a 	  series	  of	  intracellular	  mechanisms,	  including	  
MPAK	  and	  NF-­‐κβ	  ac7va7on,	  inducing	  osteoclasts	  matura7on	  and	  prolifera7on.	  It	  can	  be	  assumed	  
that	  RANK-­‐L	  ac7va7on	  by	  RANK	  promotes	  bone	  remodeling	  ac7vity.	  
-­‐ OPG:	  osteoprotogerin 	  is	  produced	  and	  secreted	  by	  osteoblast,	  it	  is 	  able	  to	  link	  to	  RANK-­‐l,	  
thus 	   blocking	   the 	   possibility	   of	   a 	   RANK/RANK-­‐l 	   interac7on	   and	   consequently	  
downregula7ng	  bone	  resorp7on.	  When	  OPG	  binds 	  RANK-­‐l,	  NF-­‐κβ	   is 	  inac7vated	  and	   it	  
stops 	  the	  promo7on	  of	   inﬂamma7on.	   OPG	   can	   be	   considered	  as 	  a	   protec7ve	   factor	  
against	  osteoclast	  promo7on.	  
-­‐ TNF-­‐α:	   tumor	   necrosis 	   factor	   alpha	   is 	   produced	   by	   macrophages,	   mast	   cells 	   and	   t	  
lymphocytes,	   it	   promotes	  macrophages	  ac7va7on	   through	  a 	  RANK/RANK-­‐l 	  dependent	  
pathway	   (Dunstan	  et	  al.	  2007).	   It	  also	  inhibits 	  osteoblasts	  prolifera7on	  by	  a 	  decrease	  in	  
the	  produc7on	  of	  extracellular	  matrix	  due 	  to	  a	  minor	  expression	  of	  osteocalcin	  and	  ALP.	  
It	  also	  s7mulates	  IL-­‐6	  produc7on.
-­‐ IL-­‐6/	  IL-­‐1:	  Interleukin	  1	  is 	  one	  of	  the	  most	  powerful 	  agent	  that	  are 	  able	  to	  promote	  bone	  
resorp7on,	   it	   is 	   secreted	   by	   macrophages,	   endothelial	   cells,	   B	   lymphocytes 	   and	  
ﬁbroblasts	  in	   two	  forms 	  (alpha 	  and	  beta).	   It	   is	  an	   inﬂammatory	   agent	   always	  present	  
during	   healing	   phases,	   it	   brings 	   to	   bone	   resorp7on	   and	   bone	   matrix	   degrada7on	  
(McCauley	  &	  Nohutcu	  2002).	  Similarly	   IL-­‐6	  is 	  a 	  pro	  inﬂammatory	  cytokine	  and	  promotes	  
bone	  resorp7on.	  Both	  interleukins 	  work	  by	   ac7va7ng	  RANK/RANK-­‐L	  pathways,	  but	  it	   is	  
important	   to	   underline 	   how	   diﬀerent	   interleukins 	   (i.e.	   IL-­‐4,	   IL-­‐10,	   IL-­‐13)	   may	   have	  
diﬀerent	  roles	  and	  in	  some	  cases	  are	  able	  to	  inhibit	  bone	  remodeling	  processes.
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2.	  Alveolar	  Socket	  Preserva.on	  
2.1 Alveolar	  process	  aLer	  tooth	  extrac.on
The	  alveolar	   process 	  is 	  a	  dynamic	  bone 	  structure 	  that	  persists	  in	  its 	  original	  morphology	  
un7l	   the	   tooth	   remains 	  in	   place;	   a@er	   the	   tooth	   loss 	   it	   goes	   into	   remodeling	   process	  
ending	  in	  a 	  complete	  new	  management	  of	  bone	  macro	  morphology.	  The	  shape 	  of	  alveolar	  
process	   is 	   determined	   by	   func7onal 	   s7mulus	   transmiaed	   by	   tooth	   and	   periodontal	  
apparatus 	  to	   the	  bone;	   when	   a	  tooth	   is 	  extracted	  or	   lost	   for	   pathological 	  reasons,	   the	  
bone	   remains 	   without	   biological 	   s7muli 	   and	   the 	   periodontal 	   lost	   ligament	   leads 	   to	  
atrophic	   situa7on	  consis7ng	  in	  dimensional	  reduc7on	  of	  bone	  crest,	  both	  in	  ver7cal	  and	  
horizontal 	  dimension	  (Atwood	  1957,	  Hedegård	  1962).	   The 	  situa7on	  of	  bone	  remodeling	  
a@er	   tooth	  extrac7on	  may	   be	   further	   worsen	  when	   pre-­‐exis7ng	   bone 	  pathologies 	  are	  
present	   in	   site 	  (periodontal 	  o	  endodon7c	   diseases)	  or	   when	   an	   incorrect	   or	   excessive	  
trauma7c	   bone	   extrac7on	   technique	   has 	   been	   used	   (Van	   der	   Weijden	   et	   al.	   2009).	  
Therefore 	  the	  correct	  management	  of	  alveolar	  socket	  healing	  is 	  fundamental 	  for	  a 	  correct	  
implant	   supported	   rehabilita7on	   technique	   that	   should	   provide	   excellent	   results 	  both	  
from	  an	  aesthe7c	  and	  a	  func7onal 	  point	  of	  view.	  The	  preserva7on	  of	  an	  important	  quote	  
of	   alveolar	   bone	  will 	  allow	   to	  place	  the	  implant	   in	   the 	  correct	   site	  and	  with	  a 	  correct	  
diameter	  and	  depth (Vignoles	  et	  al.	  2011).	  Diﬀerent	  techniques 	  and	  materials 	  have	  been	  
proposed	  to	  preserve	  alveolar	  bone	  dimension	  and	  the 	  majority	  of	  them	  will 	  be	  explained	  
in	   detail 	   later.	   It	   is 	   important	   to	   remember	   that	   in	   this 	   case 	   the	   alveolar	   socket	  
preserva7on	   technique	   represents	   an	   in	   vivo	   validated	   model 	   to	   evaluate 	   bone	  
remodeling	  paaern	  and	  it	  is 	  not	  the	  scope	  of	  the 	  authors 	  to	  evaluate 	  which	  technique	  or	  
biomaterial	  is	  more	  useful	  to	  obtain	  bone	  preserva7on.
2.2	  Physiological	  Healing
Alveolar	  bone	  healing	  a@er	  tooth	  extrac7on	  is 	  a 	  fundamental 	  maaer	  in	  implant	  den7stry	  
and	   for	   this 	   reason,	   it	   has 	  been	   widely	   studied	   in	   animal 	  models 	   and	   in	   humans.	   In	  
animals,	  in	  the	  ﬁrst	  period	  a@er	   tooth	  extrac7on,	  mainly	   in	  the	  ﬁrst	  week,	  the	  remaining	  
periodontal 	  ligament	  and	  bundle	  bone	  are	  going	  to	  be	  completely	  lost.	  As	  previously	  sad,	  
when	  the	  tooth	  is	  extracted	  the	  loss 	  of	  the	  periodontal 	  apparatus	  can	  be	  observed	  and,	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consequently,	  the 	  speciﬁc	  components 	  of	  periodontal 	  system	  disappear;	  cementum	  is 	  lost	  
with	  the	  extracted	  tooth	  and	  bundle 	  bone,	  remaining	  periodontal 	  ligament	   and	  speciﬁc	  
gingiva	  will	   be 	   remodeled	   and	   subs7tute	  with	  other	   7ssues 	  (Araujo	   &	   Lindhe,	   2005).	  
Blood	  cloth	  ﬁll 	  the	  empty	  spaces	  inside	  the	  bone	  defected	  le@	  by	  the 	  extracted	  tooth	  and	  
it	  is 	  sooner	  replaced	  by	  a 	  highly	  vascularized	  granula7on	  7ssue.	  The	  granula7on	  7ssue	  is	  
rich	   of	   new	   vessels,	   cells 	   of	   inﬂamma7on	   and	   extracellular	   matrix,	   and	   the 	  adjacent	  
7ssues	   show	   high	   presence 	  of	   ac7vated	   osteoclasts 	  and	  mul7	   nucleated	   cells 	   (Amler	  
1969).	   Star7ng	   from	   the	  end	  of	   the	  ﬁrst	   week	  of	   healing,	   ﬁlling	  7ssue	   is 	  progressively	  
subs7tuted	  by	   non	  mineralized	  bone 	  matrix.	   Bone	  matrix	   apposi7on	  starts	  from	  apical	  
and	  lateral 	  side	  of	  the	  defect	  and,	  a@er	  3-­‐4	  weeks 	  the	  new	  bone	  matrix	  occupies 	  the	  2/3	  
of	  alveolar	   defects.	  More	  in	  details 	  it	   has	  been	  observed	  the	  presence	  of	  an	  osteoblasts	  
line 	  of	  cells 	  on	  defects 	  side	  that	  tends	  to	  include	  new	  bone	  matrix	   in	  the	  central 	  part	  of	  
bone	  defect,	  but,	  in	  the	  outside	  areas 	  of	  alveolar	  bone,	  osteoclasts 	  cells 	  can	  be	  observed.	  
These	  concomitant	   factors	  may	   explain	  why,	  while	   in	  the	  inside	  part	   of	   the 	  alveolus	  is	  
usually	  observed	  new	  bone	  forma7on,	  it	  is 	  o@en	  described	  the	  lost	  of	  the	  thin	  ves7bular	  
cor7cal 	  plate,	  due 	  to	  osteoclasts 	  process 	  of	  remodeling	  in	  the	  external 	  part.	  A@er	   these	  
ini7al	  phases 	  non	  mineralized	  bone	  matrix	   starts	  to	  get	  mineralized	  and,	  progressively	   in	  
an	  external 	  to	  internal	  dynamic,	  the	  matrix	  evolves 	  in	  new	  woven	  bone.	  This 	  process 	  can	  
last	   for	   several 	  weeks,	  usually	   from	  4	  to	  8	   a@er	   tooth	  extrac7on.	   In	  the 	  majority	   of	  the	  
cases	  a@er	  six	  weeks	  it	  was	  possible	  to	  observe	  new	  mature	  bone	  and	  new	  trabeculae.
During	  this 	  bone	  remodeling	  process,	   it	   can	  be	  observed	  at	   the 	  same	  7me,	  the	  wound	  
healing	   process 	  of	   gingival 	  7ssues.	   	   From	   the	  4th	   day	   to	   the	  3rd	   week,	   epithelial 	  cells	  
migrate	  from	  the	  margins 	  of	  the	  alveolus	  in	  concentric	  direc7on,	   lining	  over	  blood	  cloth	  
and	  granula7on	  7ssue,	  and	  evolve	  in	  new	  kera7nized	  gingival	  7ssue.
Considering	  human	  models 	  the	  situa7on	  observed	  is	  slightly	   diﬀerent,	  it	  can	  be 	  said	  that	  
in	  human	   the 	  healing	   paaern	   is 	   slower	   than	   in	  other	   animals 	  as	  dogs.	   Alveolar	   bone	  
remodeling	  in	  human	  is 	  well 	  described	  by	   Trombelli 	  et	   al.	   (2008).	   The 	  authors	  collected	  
human	  biopsies	  at	   diﬀerent	   7me	   points 	  to	   describe	  human	  physiological 	  healing	   a@er	  
tooth	  extrac7on.	  In	  the 	  group	  of	  biopsies 	  collected	  in	  early	  phase	  of	  healing	  (2	  to	  4	  week	  
a@er	  extrac7on)	  the 	  36%	  of	  the 	  7ssue	  was 	  composed	  by	   granula7on	  7ssue,	  while	  in	  the	  
sample	  taken	  in	  later	   phases	  was	  not	  found	  any	   presence 	  of	  this 	  7ssue.	  The	  provisional	  
connec7ve	  7ssue 	  found	  in	  all	  7me	  points 	  was 	  composed	  by	  a	  matrix	   full 	  of	  mesenchymal	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cells,	  vascular	  structures 	  and	  osteoblasts 	  disposed	  near	  vessels	  and	  it	  varied	  in	  percentage	  
during	  the	  7meline,	   remaining	  in	  a 	  range	  between	  50	  and	  60	  %.	   The 	  bone	  matrix	  was	  
visible 	  star7ng	  from	  second	  week	  and	  was	  characterized	  by	   the 	  presence	  of	  osteoclasts	  
and	  osteoblasts,	  with	  osteoclasts 	  mainly	  present	   inside	  Howship	   lacunae.	  Mature	  bone,	  
instead,	  was	  not	   found	  in	  any	   sample	  with	  the 	  excep7on	  of	  one 	  collected	  between	  12th	  
and	   14th	   week.	   It	   was	   evident	   from	   this 	   study	   that	   there 	   was 	   a 	   high	   inter-­‐pa7ent	  
variability	   of	   the	   remodeling	   paaern	   and	   the	   repara7ve	   process	  was 	   	   in	   every	   case	  
signiﬁcantly	  slower	  than	  what	  observed	  in	  dogs.	  
Furthermore,	  in	  Trombelli 	  et	  al.	  it	  was 	  not	  only	  completed	  a 	  histomorphometrical 	  analysis,	  
but	  some	  immunohistochemical 	  were	  performed	  in	  order	   to	  describe	  more	  in 	  detail 	  the	  
biological 	  process.	  Using	  CD31	   the	  authors 	  described	  the	  varia7on	  of	  endothelial 	  cells 	  in	  
wound	  area	  and	  observed	  how	  they	  decreased	  from	  12th	  to	  24th	  week;	  this 	  was	  mainly	  
mo7vated	   by	   the	  progressive	  subs7tu7on	  of	   the	  highly	   vascularized	  granula7on	  7ssue	  
with	   bone	   provisional 	   matrix.	   BMP-­‐7	   and	   osteocalcin,	   on	   the 	   contrary,	   showed	   an	  
increasing	   expression	   from	   ini7al	   phases	   to	   6th	   and	   8th	   weeks 	   and	   a 	   decreasing	  
expression	  going	   to	   later	   phases.	   These 	  results	  are 	   in 	  concordance	  with	   other	   studies	  
(Spector	  et	  al.	  2001)	  describing	  higher	  presence	  of	  BMP-­‐7	  in	  early	  phases	  of	  healing.
2.3	  Bone	  GraLs
To	   avoid	   bone 	   7ssue	   contrac7on	   a@er	   physiological 	   remodeling,	   diﬀerent	   clinical	  
techniques 	  have	  been	   studied	   in	  order	   to	  preserve	  bone	  dimension	  and	  facilitate 	  new	  
bone	  forma7on	  inside	  the	  wound	  (Fickl	  et	  al.	  2008).
Various	   bio-­‐materials	   are 	  used	   for	   alveolar	   preserva7on	   techniques	   and	   they	   can	   be	  
synthe7cally	   divided	  into	  three 	  groups:	  ﬁlling	  materials,	   growth	  factors	  and	  membranes.	  
The	  ﬁlling	  materials 	  are	  placed	  inside	  the	  bone 	  defect	   and	  should	  be 	  able 	  to	  maintain	  
space,	   stabilize 	  cloth,	   induce	  and	  promote 	  new	   bone	   forma7on;	   growth	  factors 	  should	  
s7mulate 	  new	  bone	  forma7on	  and	  membranes	  cover	   the	  area 	  of	  the 	  defect	   in	  order	  to	  
protect	  inner	  spaces	  from	  epithelial 	  and/or	  bacterial 	  coloniza7on.	   The	  main	  goals 	  of	  the	  
preserva7on	   technique	  are	   to	   guarantee	   implant	   posi7oning	   and	   stabiliza7on,	   reduce	  
bone	   loss,	   reduce	   the	   need	   of	   a 	   secondary	   surgery,	   improve	   bone	   dimensions,	   and	  
provide	  an	  eﬃcient	  aesthe7c	  and	  func7onal	  result.
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Bone	   subs7tutes 	  act	   in	   healing	   process 	   in	   diﬀerent	   ways,	   they	   can	   promote	   3	   main	  
processes,	  but	  not	  all	  the	  materials	  are	  able	  to	  perform	  these	  3	  ways:
-­‐ Osteogenesis:	   it	   means	   the	   forma7on	   of	   new	   bone	   star7ng	   from	   gra@	   cells.	   This	  
process	  is 	  present	   only	   when	  autologous 	  bone	  is 	  used,	   because	  in	  this 	  type	  of	  bone	  
vital	  osteogenic	  cells	  are	  enclosed;
-­‐ OsteoinducCon:	   	  it	  is 	  the	  ability	  of	  the	  gra@	  to	  ac7vate	  and	  aaract	  host	  osteogenic	  cells,	  
this	  process	  is	  mediated	  by	  ac7ve	  molecules	  that	  are	  enclosed	  in	  bio-­‐materials;
-­‐ OsteoconducCon:	  it	  is 	  the 	  property	  of	  the 	  material 	  of	  being	  a 	  scaﬀold	  inside	  which,	  host	  
cells	  like	  preosteoblast,	  can	  proliferate,	  mature	  and	  produce	  new	  bone.	  
All 	  the	  materials 	  that	  are	  use	  in	  clinics 	  to	  prevent	  bone	  resorp7on	  a@er	  tooth	  extrac7on	  
are 	  able	  to	  maintain	  the	  dimensions 	  during	  7me	  in	  order	  to	  prevent	  7ssue 	  collapse,	  but	  
the	   speciﬁc	   characteris7cs 	   of	   each	   materials	   determine	   diﬀerent	   paaern	   of	   healing,	  
ending	  in	  diﬀerent	  clinical 	  results.	  In 	  the	  next	  paragraph	  the 	  major	  products	  used	  for	  this	  
scope	  will 	  be 	  exposed	  and	  explained,	  focusing	  in	  par7cular	  on	  deproteinized	  bovine	  bone	  
gra@.	  It	  was 	  decided	  to	  focus 	  on	  deproteinized	  bone 	  gra@	  because,	  despite	  it	  is 	  the	  most	  
used	   and	   described	  biomaterial,	   ar7cles	   that	   describe	  his 	   role	  and	  his	  eﬀect	   on	  bone	  
dynamics	  in	  vivo	  are	  lacking.
-­‐ Autologous	  bone:	   it	   is 	  extracted	  directly	   from	   the 	  pa7ent	  and	  it	   can	  be 	  taken	  both	  in	  
intraoral 	  site	  like	  maxillary	  tuberosity	  or	   in	  the	  mandibular	  and	  in	  extra 	  oral 	  site	  as 	  iliac	  
crest	  or	  calvaria.	  The	  autologous 	  gra@s 	  do	  not	  have	  any	   problem	  of	  biocompa7bility	   or	  
immunologic	  reac7on	  and	  they	  have	  osteogenic	  proper7es.	  They	  are	  able	  to	  promote 	  by	  
themselves 	  new	   bone	   forma7on	   because	   they	   contain	   living	   osteoblasts 	  and	   stamina	  
cells,	   but	   are	  also	  able	  to	  func7on	  as	  space	  maintaining	   scaﬀolds.	   Autologous	  bone	  is	  
remodeled	  in	  7me	  and	  completely	  subs7tute 	  with	  newly	   formed	  bone.	   It	   could	  be	  the	  
best	   gra@,	   but	   the	   morbidity	   linked	   to	   extrac7on	   sites 	   and	   the 	   limited	   dimension	  
available,	  tend	  to	  limit	  its	  use.
-­‐ Allogenic	  GraHs:	  it	  means 	  gra@s 	  derived	  by	  other	  human	  which	  are	  frozen,	  sterilized	  by	  
means 	  of	  radia7on	  and	  chemical	  agents 	  and	  ﬁnally	  stored	  in	  speciﬁc	  banks.	  These 	  gra@s	  
have	  a 	  very	  low	  risk	  of	  an7genic	  eﬀects	  and	  are	  able 	  to	  promote	  new	  bone	  forma7on	  by	  
both	  osteoinduc7ve	  and	  osteoconduc7ve	  proper7es	  (Mellonig	  et	  al.	  1981).	  These	  gra@s	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are 	  very	   easy	   to	   obtain	   in	   great	   quan7ty	   because 	  they	   are 	  available	   in 	  biologic	   bank	  
stores 	  but,	   due	   to	   the	   process 	   they	   received	   to	  make 	  them	   lose	   their	   immunologic	  
proper7es,	  they	  have	  lost	  also	  a	  great	  amount	  of	  their	  osteoinduc7ve	  ability.
-­‐	   	  Xenogenic	  graHs:	   the 	  xenogenic	   gra@	   derives	  from	  donors	  of	   diﬀerent	   species.	  The	  
most	   common	  gra@s 	  come	  from	  bovine,	  porcine	  or	   equine	  species.	  During	  steriliza7on	  
and	   demineraliza7on	   process 	  all 	   organic	   components 	  of	   the 	  gra@s	   are	   lost,	   and	   the	  
remaining	   demineralized	  por7on	   func7ons 	  as 	  scaﬀold	  which	  provides 	  an	  environment	  
where	  new	  bone	  cells 	  coming	  from	  the	  host	  are 	  able	  to	  proliferate.	  Furthermore	  these	  
gra@s 	   work	   as	   a	   calcium	   deposit.	   The	   main	   advantages	   of	   xenotrapiants 	   are 	   high	  
availability,	  osteoconduc7ve	  property	   and	  the	  lowest	  risks	  of	  immunologic	   reac7on	  and	  
cross	  infec7ons.
-­‐	   	  AlloplasCc	   graHs:	   these	  gra@s 	  have 	  a 	  synthe7c	  origin	  and	  they	   should	  be,	  as	  other	  
gra@s,	   completely	   biocompa7ble,	   resorbable,	   osteoconduc7ve	   and	   not	   inducing	  
immunologic	  reac7ons.	  Hydroxyapa7te 	  is 	  one	  of	  the	  most	  used	  allogra@	  and	  it	  is 	  an	  inert	  
material 	  with	  osteoconduc7ve	  ability,	  it	  has 	  a 	  slow	  rate 	  of	  resorp7on	  and	  func7ons 	  as	  a	  
calcium	  reserve	  in	  new	  bone 	  forma7on	  phase.	  Beta	  tricalcium	  phosphate 	  (β	   –TCP)	   is 	  a	  
porous	  form	  of	  calcium	  phosphate,	  it	   is 	  completely	   resorbed	  in 	  6-­‐18	  months,	  but	  has 	  a	  
poor	  ability	   in 	  space	  maintaining,	   for	  this 	  reason	  it	  is 	  conven7onally	  used	  in	  associa7on	  
with	  other	  materials	  or	  autogenic	  gra@s.	  Bio-­‐ac7ve	  glasses,	  HTR	  polimer	  and	  algipore 	  are	  
other	  examples	  of	  alloplas7	  gra@s.
The	  use	  of	  the 	  previously	  described	  biomaterials 	  is	  s7ll 	  controversial,	  some	  studies	  have	  
been	  conducted	  to	  verify	  if	  the	  presence 	  of	  bone 	  gra@	  represents	  a 	  beneﬁt	  or	  not,	  for	  the	  
healing	  process.	  Nahles 	  in	  2012	  compared	  post	  extrac7ve 	  sites 	  treated	  with	  biomaterial 	  or	  
leaving	  blood	  cloth	  alone,	  evalua7ng	  the 	  osteogenic	  poten7al	  of	  the	  post	  extrac7ve 	  site 	  at	  
4-­‐6	  months	  by	  means 	  of	  immunohistochemical 	  analyses. From	  their	  results 	  appeared	  that	  
osteoblas7c	   ac7va7on	   was 	  higher	   at	   4	   weeks	   a@er	   healing	   in	   both	   groups	   and	   they	  
observed	   an	   ini7al 	   new	   forma7on	   of	   bone	   in	   the	   apical 	   part	   of	   the	   defect	   and	   a	  
consequent	  migra7on	  in	  coronal	  direc7on	  through	  7me	  un7l 	  12	  weeks.	  It	  wasn’t	  possible	  
to	  ﬁnd	  any	   correla7on	  between	  biomaterial 	  and	  diﬀerent	   healing	   situa7on	  by	   analyzing	  
CBFA1/runx2	  propor7on	  and	  osteocalcin	  or	  CD31.
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2.4	  Membranes
Membranes 	  are	  fundamental 	  for	  guided	  bone	  regenera7on	  because 	  they	  work	  as 	  barrier	  
to	  protect	  bone	  defect	  from	  epithelial 	  cells	  coloniza7on.	  Melcher	   in	  1976	  ﬁrst	  described	  
the	  theory	  of	  guided	  bone	  regenera7on	  by	  membrane;	   it	  explained	  that,	  due	  to	  the	  fact	  
that	  epithelial	  cells 	  move 	  and	  grow	  faster	  than	  other	  species,	  if	  a 	  barrier	  membrane	  is 	  not	  
applied	  the 	  periodontal 	  defect	   it	  may	   be	  colonized	  by	   gingival 	  cells 	  without	   completely	  
periodontal 	  regenera7on.	   This 	  principle	  works	  correctly	   in	  periodontal 	  regenera7on,	  but	  
in	  alveolar	   socket	  preserva7on	  the	  biological	  process 	  is 	  diﬀerent	  because,	  independently	  
from	   the	  presence	  of	   a	  membrane,	   alveolar	   socket	   is	  ﬁlled	   by	   new	  bone.	   The 	  concept	  
previously	   described	  is 	  based	  on	  the	  stability	  of	  the	  blood	  cloth.	  When	  the	  blood	  cloth	  is	  
stable	  in	  alveolar	  socket,	  epithelial 	  cells 	  migrate	  over	   granula7on	  7ssue	  and	  form	  a 	  new	  
epithelial	  bridge	  over	  bone	  (Wikesjo	  et	  al.	  1992).
The	  ques7on	  in	  alveolar	  socket	  preserva7on	  is 	  on	  the	  u7lity	  of	  barrier	  membrane 	  and	  on	  
the	  ability	   of	  barrier	   membrane	   to	   improve	  spontaneous 	  healing.	   Lekovic	   et	   al.	   (1997)	  
evaluated	   the	   eﬃcacy	   of	   non	   resorbable	   barrier	   membrane 	   (e-­‐PTFE)	   for	   maintaining	  
tridimensional 	  alveolar	  bone	  dimensions.	  They	  compared	  10	   spontaneously	  healed	  sites	  
and	  10	  healed	  with	  the	  membrane	  coverage	  and	  found	  a	  beaer	  healing	  in	  test	  sites,	  with	  
beaer	  maintenance 	  of	  hight	  and	  width.	  This	  posi7ve	  result	  can	  be	  mo7vated	  by	  the	  space	  
maintaing	  ability	  of	  7tanium	  reinforced	  barrier	  membrane,	  as	  suggested	  by	  Polimeni 	  et	  al.	  
(2005),	   but	   this	  quality	   leads	  to	   other	   nega7ve	  eﬀects.	   The 	  7tanium	  reinforced	  barrier	  
membranes	   need	   to	   be	   removed	   in	   a 	  second	   stage	   and	   furthermore,	   if	   a 	  membrane	  
exposi7on	  occurs,	  it	  is 	  rapidly	  colonized	  by	  bacteria 	  and	  might	  cause	  an	  acute	  infec7on	  of	  
the	  alveolar	   socket	   during	  healing.	   For	   this 	  reason	  Lekovich	  et	   al.	   (1998)	  evaluated	  the	  
eﬃcacy	   of	  resorbable	  membrane	  (lac7de 	  polymers)	   in	  a 	  similar	  model,	   they	   compared	  
test	   group	   with	   membranes 	   and	   control 	   without.	   The	   results	   were	   similar	   to	   what	  
previously	   observed	  with	  non	  resorbable	  membrane:	   they	   obtained	  beaer	   bone	  ﬁlling	  
and	  beaer	  space	  maintenance	  in	  test	  group.
2.5	  Growth	  Factors
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To	  emphasize 	  the 	  eﬃcacy	  of	  the	  previously	  described	  biomaterial,	  diﬀerent	  growth	  factors	  
were	  adopted	  as 	  addi7onal 	  substances 	  to	  biomaterials.	  The 	  most	  used	  factors 	  are	  platelet	  
derived	   growth	   factor	   (PDGF),	   ﬁbroblast	   growth	   factor	   (FGF),	   bone	   morphogene7c	  
proteins 	  (BMP)	   and	   insulin	   like	  growth	   factor	   (IGF).	   Howell 	   in	   1997	   demonstrated	   the	  
eﬃcacy	   of	   rhBMP-­‐7	   in	  a 	  collagen	   based	   carrier	   and	   found	   signiﬁcant	   improvements 	  in	  
cor7cal 	   bone	   height	   in	   alveolar	   socket	   preserva7on	   procedures.	   Nevins	   (2005)	  
demonstrated	  the	   eﬃcacy	   of	   PDGF-­‐BB	   in	   bone 	  defect	   regenera7on	   in	   animal 	  models.	  
Despite	  these	  posi7ve	  results,	  the	  use 	  of	  growth	  factors	  in	  alveolar	  socket	  regenera7on	  is	  




Bone	  remodeling	  biologic	  paaern	  is 	  well 	  deﬁned	  in	  several 	  in	  vivo	  and	  in	  vitro	  studies	  as	  
illustrated	   in	   the	   previous 	  pages,	   but	   the	   inﬂuence	   of	   bone	   subs7tutes	   on	   individual	  
healing	   paaern	   in	   human	   is 	  not	   completely	   detailed	   and	  described.	   In	   order	   to	   avoid	  
invasive 	  procedures 	  necessary	  for	  autologous	  bone	  collec7on,	  bone	  subs7tutes 	  have 	  been	  
widely	   used	  and	   described	   in	   periodontal	   regenera7on,	   socket	   preserva7on	   and	  bone	  
regenera7on	   technique.	   Deprotenized	   bovine	   bone 	   (Bio-­‐Oss®,	   Geistlich	   Pharma	   AG,	  
Switzerland)	  (DBB)	  is	  a 	  bovine 	  subs7tute	  derived	  from	   bovine 	  bone	  deprived	  of	  all 	  the	  
organic	  components	  and	  reduced	  in	  porous	  grains 	  of	  diﬀerent	  dimensions	  (0.25	  -­‐	  2	  mm)
(Gross	  1997).	   Preclinical 	  studies 	  widely	   described	   the	  biocompa7bility	   of	   deprotenized	  
bovine	  bone 	  and	   the	   integra7on	  of	   this 	  biomaterial 	  in	   the	   regenerated	  bone	  (Isaksson	  
1992,	   Berglundh	  &	   Lindhe 	  1997,	   Araujo	   et	   al.	   2008,	   2009,	   2011)	   and	   various 	  clinical	  
papers	  and	  reviews 	  proved	   the	  clinical 	  beneﬁts	  of	   this 	  gra@	   in 	  regenera7on	  procedure	  
(Trombelli	  et	  al.	  2002,	  Mardas	  et	  al.	  2010,	  Urban	  &	  Lozada	  2010,	  Stavropoulus	  &	  Karring	  
2010,	  Silvestri	  et	  al.	  2010,	  Nevins 	  et	  al.	  2006,	  Esposito	  et	  al.	  2008,	  Baldini 	  et	  al.	  2011).	  The	  
ini7al	  histomorphometric	   data	  on	   Bio-­‐oss 	  remodeling	  were 	  described	  by	   Becker	   et	   al.	  
(1998).	   The	   authors 	   reported	   that,	   3	   to	   7	   months 	   later	   of	   DBB	   placement	   in	   fresh	  
extrac7on	  socket,	   the	  DBB	  par7cles 	  were	  found	   surrounded	  by	   connec7ve	  7ssue 	  with	  
marginal 	  presence	  on	  new	  woven	  bone.	   Carmagnola 	  et	   al.	   (2003)	   tried	  to	   verify	   these	  
data 	  on	  21	  post-­‐extrac7ve	  socket	  and	  found	  a 	  result	  comparable	  to	  Becker	  et	  al.;	  the 	  DBB	  
at	  the	  9	  month	  evalua7on	  was 	  observed	  to	  be	  comprised	  in	  a	  connec7ve	  7ssue	  with	  small	  
percentage 	  of	  new	  woven	  bone,	  the	  central 	  part	  of	  the	  gra@ed	  site 	  was	  characterized	  by	  
DBB	  par7cles 	  with	   surrounding	  connec7ve 	  7ssue,	  but	   the 	  peripheral 	  part	   showed	  new	  
bone	  forma7on.	  The	  authors	  observed	  also	  that	  the	  quality	  and	  the	  quan7ty	  of	  the	  bone	  
in	  the	  DBB	  group	  was 	  clinically	  suﬃcient	  for	  a 	  correct	  implant	  placement,	  the 	  dimension	  
of	   the 	  extrac7on	  socket	   site	  was 	  preserved.	   Rasperini 	  et	   al.	   (2010)	   in	  the	  same 	  clinical	  
model	  reported	  that	  at	  3	  months	  the	  DBB	  was	  s7ll 	  in	  a	  remodeling	  phase	  surrounded	  by	  
connec7ve	  7ssue	  and	   at	   6	   and	   9	   months 	  the	  DBB	  par7cles 	  s7ll 	  remained	   in	   site,	   but	  
included	   in	  mature	  new	  formed	  bone.	   Sartori 	  et	  al.	   (2003)	  reported	  the	  rate 	  of	  Bio-­‐oss	  
resorp7on	  in 	  a 	  clinical 	  case	  of	   sinus 	  li@	   with	  histomorphometric	   analysis 	  at	   8	   months	  
(29.8%	  of	  autologous 	  bone	  and	  70.2%	  Bio-­‐oss),	  2	  years 	  (	  69.7%	  autologous)	  and	  10	  years	  
(86.7%	   autologous),	   underlying	   the 	   long	   term	   scaﬀold	   ability	   of	   the	   DBB	   gra@.	  
Mordenfeld	  et	  al.	  (2010)	  reported	  similar	  data 	  on	  the	  11	  year	  histomorphometric	  analyses	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of	   11	   pa7ents 	   treated	   with	   sinus 	   li@	   procedures 	   using	   Bio-­‐oss	   (80%	   Bio-­‐oss,	   20%	  
autologous),	   it	  was	  found	  44.7	  +/-­‐	  16.9%	  of	  lamellar	  bone,	  38+/-­‐16.9%	  of	  marrow	  space	  
and	  17.3+/-­‐13.2%	  of	  residual	  DBB.	  
The	  reason	  of	  this 	  low	  rate	  of	  DBB	  gra@	  resorp7on	  observed	  in	  vivo	  was 	  also	  inves7gated	  
in	  vitro,	   evalua7ng	   genic	   expression	   of	   osteoblast	   induced	  by	   the	  presence	  of	   Bio-­‐oss	  
par7cles 	  in	  early	   phase 	  of	  healing.	  Kubler	  (2004)	  compared	  4	  diﬀerent	  bone 	  subs7tutes	  
and	   found	   that	   DBB	   showed	   a 	   lower	   prolifera7on	   and	   diﬀeren7a7on	   poten7al 	   on	  
osteoblasts.	   Thurani	  (2005)	   reported	  similar	   results,	   the	  authors 	  observed	   less	  alkaline	  
phosphatase	   ac7vity	   in	   cells	   cultured	   on	   DBB	   substrate 	   and	   less 	   osteopon7n	   and	  
osteocalcin	   gene	   expression	   than	   cell 	   growth	   on	   other	   bone	   subs7tute.	   The 	   genic	  
expressions 	   of	   proteins 	   involved	   in	   osteoblast	   diﬀeren7a7on	   and	   proinﬂammatory	  
cytokines	  in	  a 	  culture	  of	  osteoblast	  in	  contact	  with	  DBB	  were	  inves7gated	  by	  Amerio	  et	  al.	  
(2010).	  The	  results 	  showed	  a	  signiﬁcantly	   lower	   expression	  of	  bone	  sialoprotein,	  BMP-­‐2	  
and	  BMP-­‐7	  	  in	  culture	  with	  DBB	  and	  also	  the	  expression	  of	  TNF-­‐α	  and	  IL-­‐6	  was 	  signiﬁcantly	  
reduced	  in	  DBB	  culture.	  
These	  in	  vitro	  papers	  may	  be	  models 	  that	  explain	  the 	  slow	  rate 	  of	  DBB	  resorp7on,	  but	  no	  
published	   scien7ﬁc	   study	   in	   vivo	  has 	  conﬁrmed	   these	  data.	   Furthermore	  these 	  in	  vitro	  
studies 	  evaluated	  osteoblast	  cell 	  response 	  in	  a	  model 	  that	  reproduces	  early	  healing	  phase,	  
but	  any	  studies	  have	  described	  the	  eﬀect	  of	  DBB	  on	  genic	  expression	  in	  late	  phase 	  of	  bone	  
remodeling.	  
4.	  Aim
The	  aim	  of	  the	  present	  research	  is 	  to	  describe 	  the	  remodeling	  paaern	  of	  DBB	  in	  human	  
socket	  alveolar	  preserva7on	  in	  the 	  late	  phase	  of	  healing.	  The	  purpose	  of	  this	  inves7ga7on	  
is 	  to	  verify	   if,	  ﬁve	  months	  a@er	  extrac7on,	  the 	  remaining	  DBB	  par7cles 	  s7ll 	  inﬂuence	  bone	  
remodeling	  paaern	  downregula7ng	  osteoblast	  diﬀeren7a7on	  and	  cytokine	  expression,	  as	  
already	   described	   in	   the 	   previously	   cited	   in	   vitro	   studies.	   This	   hypothesis 	   of	   low	  
expression	  of	  bone 	  remodeling	  marker	   due	  to	  the	  presence	  of	  remaining	  DBB	  par7cles	  
included	  in	  new	  formed	  bone,	  may	  jus7fy	  the	  results 	  clinically	  and	  histologically	  described	  
in	  literature.
5.	  Materials	  and	  Methods
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This 	  is 	  a	  clinical 	  trial 	  designed	  to	  describe	  the	  DBB	  remodeling	  paaern	  in	  alveolar	  socket	  
preserva7on	   procedure.	   A@er	   tooth	   extrac7on,	   a	  biopsy	   of	  bone	  7ssue	  was	  harvested	  
from	  the	  treated	  site 	  for	  analysis	  of	  histological 	  features 	  and	  gene	  expression	  at	  baseline.	  
Then	  the 	  alveolar	  socket	  was	  randomized	  in	  sites	  gra@ed	  with	  Bio-­‐oss 	  and	  sites 	  le@	  healed	  
spontaneously.	   Five 	  months	  a@er	   the	   surgery,	   at	   the 	  implant	   placement	   appointment,	  
some 	  hard	  7ssue 	  samples 	  were	  harvested	  for	  analysis	  of	  histological 	  features 	  and	  gene	  
expression.	  These 	  7ssue	  samples 	  were	  treated	  at	  Università	  degli	  Studi	  di 	  Milano,	  Dept.	  of	  
Biomedical 	  Science 	  for	  Health	  and	  Dept.	  of	  Biomedical,	  Surgical 	  and	  Dental 	  Sciences.	  The	  
expression	  of	  ALP,	  BMP-­‐2,	  BMP-­‐7,	  IL-­‐6,	  TNF-­‐α	  in	  hard	  7ssue 	  at	  baseline	  and	  5	  months	  a@er	  
surgery	  was	  evaluated	  by	  immunohistochemical	  reac7on.
5.1	  Study	  popula.on
A	  total	  of	  20	  pa7ents	  sa7sfying	  the	  following	  criteria	  has	  been	  iden7ﬁed.
Inclusion	  Criteria:
-­‐	  necessity	  of	  tooth	  extrac7on	  
-­‐	  age	  >	  18	  years	  old
-­‐	  signed	  informed	  consent
-­‐	  no	  relevant	  systemic	  disease
-­‐	  no	  an7bio7cs	  therapy	  in	  the	  previous	  four	  months
-­‐	  non	  smoking
-­‐	  FMPS	  and	  FMBS	  <	  15	  %	  
Exclusion	  Criteria:
-­‐	  pregnancy	  or	  lacta7on	  woman
-­‐	  peri-­‐apical	  endodon7cs	  disease
-­‐	  suppura7ve	  periodontal	  pocket
-­‐	  history	  of	  biphosphonate	  therapy
-­‐	  periodontal	  disease	  on	  adjacent	  tooth
-­‐	  absence	  of	  buccal	  cor7cal	  wall
Informed	  consent	  was 	  obtained	  from	  all 	  subjects 	  to	  be 	  entered	  in	  the 	  study.	  In	  obtaining	  
the	   informed	   consent	   and	   in	   the	   conduct	   of	   the	   study,	   the	   principles 	  outlined	   in	   the	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Declara7on	  of	  Helsinki	  on	  experimenta7on	  involving	   human	   subjects	  were	  adhered	  to.	  
The	  study	   protocol 	  received	  the	  approval 	  by	   Ethic	   Commiaee	  of	  University	   of	  Milan	   in	  
20th	  July	  2011.	  At	  each	  visit	  the	  clinician	  evaluated	  pa7ents 	  for	  any	  untoward	  eﬀects.	   In	  
case	   a 	  pa7ent	   required	   any	   treatment	   during	   the	   course	   of	   the	   study,	   the 	  necessary	  
treatment	   was	  provided	  at	   the	  discre7on	  of	   the	  clinician	  and	  according	   to	   the 	  current	  
standard	  of	  care.	  	  
5.2	  Randomiza.on
Each	  pa7ent	   included	  in	  the	  study	   needed	  tooth	  extrac7on	  and	  implant	   replacement	   in	  
one 	  single	  site.	  Every	  pa7ent	  represents 	  a	  single 	  unit	  and	  was 	  randomly	  assigned	  to	  test	  
group	   (alveolar	   socket	   preserva7on	  with	  DBB)	   or	   control 	  group	  (spontaneous	  healing).	  
The	  clinic	   discovered	  which	  technique	  to	  use	  only	   a@er	   tooth	  extrac7on,	  by	   opening	   a	  
closed	  envelope	  containing	  indica7on	  to	  test	  or	  control.	  The 	  20	  envelopes 	  were	  prepared	  
by	  a	  blind	  operator	  and	  randomly	  assigned	  to	  the	  scheduled	  pa7ents.
5.3	  Surgical	  Procedure
The	  teeth	  were	  extracted	  using	  a	  ﬂapless,	  minimally	   invasive	  technique	  (Fig.1).	  A@er	  tooth	  
extrac7on	  bone	  samples 	  were	  collected	  in	  the 	  lateral	  side	  of	  the	  alveolus	  using	  a 	  trephine	  
(internal 	  diameter	   2.0mm,	   Hu-­‐Friedy,	   Usa).	   In	   presence 	  of	   an	   infra-­‐osseous 	  defect	   the	  
bone	  sample	  was	  taken	  in	  the	  opposite	  side	  of	  the	  alveolus.	  
22
Fig.	  1	  Infraosseus	  defect	  a@er	  tooth	  extrac7on.
Thus	   in	   test	   group,	   the 	   hard	   7ssues 	   were	   cureaed,	   and	   Bio-­‐oss 	   granules 	   (Bio-­‐Oss®	  
0.25-­‐1mm,	  Geistlich	  Pharma	  AG,	  Switzerland)	  were 	  gra@ed	  into	  the	  socket	   up	  to	  2	  mm	  
apical 	   to	   the	   so@	   7ssue	  margin	   (Fig.2).	   A	   resorbable 	  membrane 	   (Bio-­‐Gide®,	   Geistlich	  
Pharma	  AG,	  Switzerland)	  was 	  used	  to	  cover	   the 	  alveolar	   socket,	  and	  a	  criss 	  cross	  suture	  
with	  5-­‐0	  Gore-­‐tex	  was	  realized	  to	  stabilize	  the	  gra@	  (Fig.3).
In	  control 	  group	  a@er	   tooth	  extrac7on	  the	  hard	  7ssues	  were	  cureaed	  and	  a	  cross	  suture	  
with	  5-­‐0	  Gore-­‐tex	  was	  realized	  over	  the	  extrac7on	  site.	  
Fig.	  2	  Alveolar	  socket	  gra@ed	  with	  DBB
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Fig.	  3	  Alveolar	  socket	  closed	  with	  sutures.
Post-­‐opera7ve	  pain	  and	  edema	  were 	  controlled	  with	  ibuprofen.	  Pa7ents 	  received	  600	  mg	  
at	  the	  beginning	  of	  the	  surgical 	  procedure	  and	  were 	  instructed	  to	  take 	  another	   tablet	  6	  
hours 	  later.	  Subsequent	  doses 	  were 	  taken	  only	   if	  necessary	   to	  control 	  pain.	  Pa7ents	  with	  
ulcers,	  gastri7s,	  and	  other	  contraindica7ons	  to	  NSAIDs	  received	  500	  mg	  acetaminophen.	  
In	   these	   cases,	   the	   second	   dose 	   was 	   a@er	   6	   hours.	   All	   pa7ents	   were	   instructed	   to	  
intermiaently	  apply	  an	  ice	  bag	  on	  the 	  operated	  area 	  (5	  min	  yes,	  5	  min	  no,	  for	  the	  ﬁrst	  2	  
hours).	  All 	  pa7ents 	  were	  instructed	  to	  discon7nue	  toothbrushing	  and	  avoid	  trauma	  at	  the	  
surgical 	  site.	  A	   60	   second	   rinse	  with	  0.12%	  chlorhexidine	  digluconate	  was 	  prescribed	  3	  
7mes/day	  for	  the	  ﬁrst	  2	  weeks.	  
The	  sutures	  were	  removed	  a@er	   10	  days.	   Pa7ents 	  were 	  instructed	  to	  brush	  with	  a 	  post-­‐
surgical 	   so@	   toothbrush	   for	   the	   following	   weeks,	   resuming	   interdental 	   cleaning.	   Two	  
weeks 	  a@er	   surgery,	   the	  pa7ents 	  were	   instructed	   to	   resume	  regular	   mechanical 	  tooth	  
cleaning	  of	  the	  treated	  areas	  using	  a 	  regular	   toothbrush	  with	  the 	  appropriate 	  technique.	  




At	   the 	  5	   months	   appointment	   (T1)	   a 	   re-­‐entry	   procedure 	  was	   performed.	   A@er	   topic	  
anesthesia	  a 	  full-­‐thickness 	  ﬂap	  was 	  raised	  and	  using	  a 	  trephine	  (internal	  diameter	  2.0	  mm,	  
Hu-­‐Friedy,	  Usa),	  bone	  specimens	  were	  collected	  before 	  implant	  placement.	  A@er	  implant	  
placement	   a	   single	   interrupted	  5.0	  monoﬁlament	   (Gore-­‐tex)	   sutures 	  was	  used	  for	   ﬂap	  
adapta7on.
At	  baseline	  was 	  collected	  one	  bone	  biopsy	  with	  trephine 	  int.	  diam.	  2	  mm	  (3	  mm	  depth)	  
(immunohistological 	  analysis)	   and	   at	   5	   months	   were	   collected	   two	   bone 	  biopsy	   with	  
trephine	  int.	  diam.	  2	  mm	  (3	  mm	  depth)	  immunohistological/histomorphometric	  analysis)	  
5.4	  Histologic	  Processing
The	  specimens 	  taken	  at	  T0	  were	  immersed	  in	  10%	  formalin/0.1	  mol/L	  phosphate-­‐buﬀered	  
saline	   (pH	   7.4)	   for	   24	   hours 	  at	   room	   temperature	   and	   then	   decalciﬁed	   for	   2	   days 	   in	  
ethylenediaminetetraace7c	   acid	   decalciﬁca7on	   product.	   A@er	   that,	   decalciﬁca7on	   was	  
veriﬁed	  with	  a 	  radiograph,	  the 	  bone	  cores	  were	  rinsed	  with	  running	  water	   for	  24	  hours,	  
rou7nely	   dehydrated	  in	  a	  series 	  of	  increasing	  concentra7ons	  of	  ethanol 	  (50%,	  70%,	  80%,	  
90%,	   96%,	   100%);	   placed	   in	   xylol 	  for	   12	   hours,	   and	  then	   embedded	  in 	  paraﬃn.	   Serial	  
longitudinal 	  sec7ons 	  of	  about	  5	  µm	  were	  stained	  with	  haematoxylin/eosin	  (Sigma-­‐Aldrich,	  
St	   Louis,	   MO).	   The	   slices 	   a@er	   immuohistochemical 	   staining	   were	   observed	   and	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photographed	  under	   a	  Nikon	  light	  microscope	  (Eclipse	  E600)	  equipped	  with	  a	  calibrated	  
digital	  camera	  (DXM1200,	  Nikon,	  Tokyo,	  Japan).
In	  each	  pa7ent	  two	  bone 	  biopsy	  were	  harvested	  at	   T1.	  One 	  biopsy	  was 	  decalciﬁed	  and	  
paraﬃn-­‐included	  as	  described	  in	  the	  previous 	  paragraph,	  the 	  other	  biopsy	  was 	  prepared	  
for	   light	   microscopy	   without	   prior	   demineraliza7on	  in	   accordance	  with	   the	  method	  of	  
Donath	  &	   Breuner	   in 	  1982.	   In	  brief,	   the	  undecalciﬁed	   bone	  samples 	  was 	  ﬁxed	   in	   10%	  
formalin/0.1M	   phosphate 	   buﬀer	   saline	   solu7on,	   dehydrated	   by	   increasing	   ethanol	  
concentra7ons,	   inﬁltrated	   and	   embedded	   in	   Kulzer	   Technovit	   7200	   VLC	   (Bio-­‐Op7ca,	  
Milano,	  Italy).	  Two	  longitudinal	  midsec7ons 	  were 	  obtained	  per	  block	  using	  a	  diamond	  saw	  
(Micromet	   &	   LS2,	   Remet,	   Remet,	   Bologna,	   Italy),	   grounded	  and	   polished	   (LS2,	   Remet,	  
Bologna,	  Italy)	  to	  a 	  ﬁnal	  thickness	  of	  about	  50μm.	  The	  sec7ons 	  were	  mounted	  on	  plas7c	  
slides,	  stained	  with	  toluidine	  blue/pyronine 	  G	  (Sigma-­‐Aldrich,	  St	  Louis,	  MO)	  and	  observed	  
using	  a 	  Nikon	  light	  microscope 	  (Eclipse 	  E600)	  equipped	  with	  a 	  calibrated	  digital 	  camera	  
(DXM1200,	   Nikon,	   Tokyo,	   Japan).	   The	   undecalciﬁed	   sec7on	   was 	   analyzed	   by	  
histomorphometry.	  The	  decalciﬁed	  part	  was	  used	  for	  immunohistochemistry.	  
Histomorphometric	  measurements	  of	  the 	  7ssue	  frac7ons	  (marrow	  spaces,	  DBB,	  lamellar	  
bone)	   in	   the 	  samples 	  were	   performed	  on	   images 	  at	   a 	  magniﬁca7on	   of	   100×	   using	   a	  
standard	   stereologic	   method.	   A	   point-­‐coun7ng	   grid	   consis7ng	   of	   100	   test	   points 	  was	  
placed	   over	   each	   microscopic	   image 	   sec7on	   and	   the 	   7ssue 	   underlying	   each	   grid	  
intersec7on	  were	  recorded	  as 	  either	  new	  bone,	  residual 	  hydroxyapa7te	  or	  bone	  marrow	  
spaces.	  The 	  number	  of	  hits 	  containing	  new	  bone,	  gra@ed	  par7cles 	  or	  marrow	  spaces 	  were	  
separately	   divided	  by	   the 	  total 	  number	  of	  possible 	  intersec7ons 	  and	  thus	  expressed	   in	  
percentage	  values	  represen7ng	  the	  volume	  density	  of	  these	  3	  components.	  
On	  decalciﬁed	  sec7ons 	  immunohistochemical 	  inves7ga7ons	  were 	  performed	  to	   iden7fy	  
anabolic	   (alkaline	   phosphatase 	   [ALP],	   Bone	  Morphogene7c	   Proteins 	  2	   and	   7	   [BMP-­‐2],	  
[BMP-­‐7])	  and	  catabolic	  bone	  markers	  (	  TNF-­‐α	  and	  IL-­‐6).	  
More 	   in	   detail,	   the	   an7gen	   retrieval 	  was 	  done	   with	   Proteinase	   K	   solu7on	   at	   37°	   in	  
humidiﬁed	   chamber	   for	   20	   minutes.	   Four	   sec7ons 	  for	   each	  sample	  were	   incubated	   at	  
room	   temperature	   for	   90	   minutes 	   with	   the 	   following	   an7bodies 	   ALP	   (alkaline	  
phosphatase,	   1:100,	   Santa	   Cruz	   Biotech,	   inc.,	   Santa 	   Cruz,	   CA,	   USA),	   BMP-­‐2	   (Bone	  
Morphogene7c	  Proteins 	  2,	   1:200,	  Santa	  Cruz	  Biotech,	  inc.,	  Santa	  Cruz,	  CA,	  USA),	  BMP-­‐7	  
(Bone	  Morphogene7c	   Proteins 	  7,	   1:200,	   Santa 	  Cruz	  Biotech,	   inc.,	   Santa 	  Cruz,	   CA,	  USA),	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TNF-­‐α	  (Tumor	  Necrosis 	  Factors 	  α,	  1:100,	  Santa	  Cruz	  Biotech,	  inc.,	  Santa	  Cruz,	  CA,	  USA)	  and	  
IL-­‐6	  (Interleukin	  6,	  1:100,	  Santa	  Cruz	  Biotech,	   inc.,	  Santa	  Cruz,	  CA,	  USA).	  To	  have 	  control	  
sec7ons,	   treatment	   with	   primary	   an7body	   was	   omiaed	   in	   selected	   sec7ons.	   Then	  
sec7ons 	   were	   washed	   with	   PBS	   solu7on	   for	   four	   7mes	   for	   5	   minutes,	   immersed	   in	  
labelling	   solu7on	   (Ultravision	   Quanto	   Detec7on	   System	   HRP,	   Thermo	   Scien7ﬁc,	  
Loughborough,	   Leicestershire,	   UK)	  and	  stained	  with	  DAB	  (diaminobenzidine,	   Ultravision	  
DAB,	  Thermo	  Scien7ﬁc).	  All	  the	  sec7ons	  were	  counterstained	  with	  Mayer’s	  haematoxylin.	  
For	  each	  marker	   4	  sec7ons 	  (2	  marked	  and	  2	  controls)	   per	   specimen	  were	  analyzed.	   All	  
markers 	  were	  quan7ﬁed	  using	  a	  speciﬁc	  image	  analysis 	  so@ware	  (Photoshop	  CS5,	  Adobe	  
System)	   at	   a	   total 	  magniﬁca7on	   of	   400X	   and	  4X.	   	   It	   was 	  decided	   a 	  color	   range	   that	  
represented	  marked	  cells 	  and	   it	  was	  calculated	  the	  frac7on	  of	  marked	  pixels	  over	   total	  
pixels	  of	  the	  en7re	  image.	  
5.5	  Sta.s.cal	  Analyses
The	  aims 	  of	   the 	  sta7s7cal	  analyses 	  are 	  to	   compare 	  T0	   and	   T1	   in	  both	  groups,	   and	  to	  
compare	   test	   and	   control 	   normalized	   diﬀerence	   between	   T0	   and	   T1.	   Normalized	  
diﬀerence	  was	  calculated	  as 	  (T1-­‐T0)/T0.	   Sta7s7cal 	  analyses	  were 	  performed	  with	  Kyplot	  
so@ware 	  (Kyplot,	  2012,	  KyesnLab	  INC)	  :	  non	  parametric	  tests 	  for	  paired	  (Wilcoxon	  signed	  




It	  was 	  analyzed	  on	  non	  decalciﬁed	  samples	  the	  frac7ons 	  of	  diﬀerent	  7ssues.	  At	  T1	  in	  test	  
sample	  it	  was 	  found	   	  33.4%	  of	  DBB,	  14.6%	  of	  lamellar	  bone,	  25.8%	  of	  osteoid	  and	  26.2%	  
of	  bone	  marrow.	  At	  T1	   in	  control	  group	   it	  was	  found	  30.6%	  of	   lamellar	   bone,	  29.3%	  of	  
osteoid	  and	  40.1%	  of	  medullary	   space.	  These 	  data 	  are	  shown	  in	  the	  graphics 	  below	  (Fig.
5-­‐8).
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Fig.5	  Frac7ons	  in	  Bio-­‐oss	  group.















Fig.7	  Details 	  at	   200X	   total	  magniﬁca7on	  of	  DBB	  par7cles 	  surrounded	  by	  osteoid	  at	  T1	   in	  
test	  group.
Fig.8	   Details 	  at	   200	   X	  magniﬁca7on	  of	   T1	   in	   test	   group.	   LB:	   lamellar	   bone	  WB:	   woven	  




6.2	  Hematoxylin	  &	  Eosin
The	  observa7on	  at	  microscope	  of	   the	  non	  decalciﬁed	  sec7on	  stained	  with	  hematoxilin-­‐
eosin	  conﬁrmed	  that	  all 	  the	  bone	  samples 	  at	  T0	  were 	  healthy,	  without	  evidence	  of	  acute	  
inﬂamma7on.	   A@er	   laboratory	   process 	   the 	   samples 	  morphology	   appeared	   to	   be 	  well	  
preserved,	   conﬁrming	  the	  absence	  of	  modiﬁca7on	  due	  to	  eventual 	  procedure	  errors.	   It	  
was	  possible	  to	  iden7fy	   all 	  the	  morphologic	  characteris7cs	  of	  the	  sample:	  compact	  bone	  
results 	  well 	  organized	  in	  lamellar	  structure.	  Osteocytes 	  were	  stained	  with	  violet	  color	  and	  
were	  clearly	  visible	  in	  lacunae	  inside	  bone	  matrix.	  The	  medullar	  spaces 	  appeared	  rich	  of	  
collagen	   ﬁbers 	  and	   various	   cells 	   coming	   from	   blood	   vessels.	   At	   T1	   in	   the	   test	   group	  
biomaterial 	   par7cles 	   were	   clearly	   visible,	   but	   without	   any	   sign	   of	   inﬂamma7ons.	   In	  
proximity	   of	   DBB	   par7cles	  there	  was 	  presence 	  of	   immature 	  bone	  matrix,	   which	  was 	  a	  
clear	  sign	  of	  new	  bone	  forma7on	  surrounding	  gra@s.	  The 	  osteoblast	  that	  were 	  visible	  in	  
this 	   area 	  were	   another	   sign	   of	   bone	   remodeling	   process.	   In	   the	  majority	   of	   the	   test	  
sample	  it	  was 	  not	  possible	  to	  ﬁnd	  high	  presence	  of	  new	  lamellar	  bone,	  on	  the	  contrary,	  in	  
the	   spontaneously	   healed	   control 	   group,	   it	   was	   easier	   to	   ﬁnd	   new	   mature	   bone.	  
Complementary	  in	  T1	  test	  group	  there	  was	  more	  collagen	  then	  what	  observed	  in	  T0	  or	  in	  
control	  cases	  (Fig.9).
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Fig.9	  T0	  samples	  with	  e-­‐e	  staining.
6.3	  Immunohistochemistry
For	  every	   specimen	  a	  semiquan7ta7ve	  analysis 	  was 	  done 	  to	  evaluate	  the 	  percentage	  of	  
marked	   pixels 	   over	   total 	   pixels	   of	   the	   images 	   and	   the	   mean	   normalized	   diﬀerences	  
between	  T0	  values 	  and	  T1	  values	  in	  both	  groups 	  were	  calculated.	  The	  results 	  are	  shown	  in	  









BMP-2 BMP-7 ALP IL-6 TNF α
+ 0.67 + 0.36 -0.28 + 0.81 + 1.09
0.43 0.23 0.18 0.6 0.85
63.74 64.22 62.65 74.39 77.82
BMP-2 BMP-7 ALP IL-6 TNF α
+ 1.42 + 0.1 -0.23 + 0.45 -0.01
0.11 0.13 0.15 0.8 1.3
7.62 66.62 61.97 68.43 77.82
Fig.10	  Normalized	  diﬀerence	  between	  T0	  and	  T1	  value	  in	  both	  groups.	  S.D.	  =	  Standard	  
Devia7on	  C.V.	  =	  Coeﬃcient	  of	  varia7on
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Fig.11	  Normalized	  diﬀerence	  between	  T0	  and	  T1	  in	  test	  group
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BMP-­‐2
BMP-­‐2	  marking	  was	  clearly	  visible 	  in	  both	  groups 	  at	  T0	  and	  T1,	  but	  in	  the 	  T0	  stages 	  it	  was	  
prevalent	   an	   intracellular	  marking,	  while 	  at	  T1	   in	  both	  group	   it	  was	  no7ced	  an	  evident	  
staining	  also	  outside	  cells,	   near	  gra@	   in	  bone	  matrix	   and	  between	  collagen	  ﬁbers.	  Bone	  
mineralized	  matrix	   is 	  stained	  with	  BMP-­‐2	  in	  all 	  the 	  samples,	  but	   it	  can	  be 	  seen	  a	  denser	  
colora7on	  in	  both	  5	  month	  bone	  samples.	  	  (Fig.13-­‐17)
Fig.13	  BMP-­‐2	  staining	  in	  T1	  test	  in	  proximity	  of	  DBB	  par7cles.	  200X	  total	  magniﬁca7on.
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Fig.14	  	  Diﬀuse	  BMP-­‐2	  staining	  in	  collagen	  matrix	  at	  400X	  total	  magniﬁca7on	  in	  T1	  Test.




Fig.16	  Mul7nucleated	  cells	  marked	  with	  BMP-­‐2	  at	  200X	  total	  magniﬁca7on	  at	  T0.
Fig.17	  Images	  of	  BMP-­‐2	  stained	  samples	  at	  T0,	  T1	  in	  DBB	  group	  and	  T1	  in	  control	  group.	  It	  




BMP-­‐7	  marking	  was 	  denser	  in	  bone	  medullary	  spaces 	  at	  T0	  and	  T1	  in	  both	  groups 	  and	  was	  
completely	   absent	  in	  lamellar	  bone,	  showing	  a 	  completely	  diﬀerent	  paaern	  of	  staining	  in	  
comparison	  to	  what	  observed	  with	  BMP-­‐2.	  Inside	  medullary	  spaces 	  it	  can	  be 	  seen	  both	  an	  
intracellular	   and	  extracellular	   staining,	   in	  par7cular	   there	  is	  a 	  high	  presence	  of	  posi7ve	  
marking	   on	   collagen	   ﬁbers 	   at	   T0	   and	   T1	   7me	   points.	   Despite	   the	   absent	   staining	   in	  
lamellar	  bone,	  osteocytes	  cells,	  trapped	  inside	  mineralized	  bone,	  are	  clearly	  marked.	  
	  (Fig.	  18-­‐22)
Fig.18	  Comparison	  of	  BMP-­‐2	  and	  BMP-­‐7	  marking	  in	  TO	  samples	  (ﬁrst	  image)	  and	  T1	  
samples	  (second	  image)
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Fig.19	  BMP-­‐7	  staining	  at	  T0,	  200X	  total	  magniﬁca7on.	  	  	  




Fig.21	  BMP-­‐7	  staining	  at	  T1	  in	  control	  group	  at	  200X.




ALP	  is 	  situated,	  in	  all 	  the	  analyzed	  samples,	  in	  the 	  periphery	  of	  mineralized	  lamellar	  bone,	  
it	   shows 	  clearly	   the 	  line	   of	   new	  bone	   forma7on.	   It	   is 	  absent	   near	   the	  gra@	   par7cles,	  
conﬁrming	  the	  new	  bone	  forma7on	  in	  direct	  contact	  with	  DBB	  (Fig.	  23-­‐26).
Fig.23	  ALP	  in	  samples	  at	  T0,	  T1	  test	  and	  T1	  control
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Fig.24	  ALP	  marking	  at	  T0	  at	  400x	  magniﬁca7on.




Fig.26	  ALP	  marking	  at	  T1	  at	  400X	  magniﬁca7on	  in	  control	  sample.
IL-­‐6
Interleukin 	  6	   is 	  mainly	  distributed	  in	  extracellular	  sides 	  in	  medullary	   spaces,	  and	  appears	  
to	  be 	  not	  organized	  and	  diﬀused	  in	  spot	  between	  collagen	  ﬁbers.	  It	  is	  mainly	  produced	  by	  
osteoclasts	  and	  osteoblasts 	  and	  should	  s7mulate	  the	  bone	  resorp7on.	  For	  this 	  reason	  it	  is	  
visible	  near	  the	  gra@	  par7cles,	  in	  osteoid	  matrix	  (Fig.	  27-­‐30).
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Fig.27	  IL-­‐6	  marking	  at	  T0,	  T1	  in	  test	  group	  and	  control.
Fig.28	  IL-­‐6	  marking	  at	  200X	  magniﬁca7on	  at	  T0.
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Fig.29	  IL-­‐6	  marking	  at	  T1	  in	  test	  group	  at	  200X	  total	  magniﬁca7on.	  It	  is	  visible	  a	  high	  
marking	  of	  IL-­‐6	  near	  DBB	  par7cles.





In	  both	  groups 	  at	  T0	  and	  T1	  similar	  results 	  were	  observed,	  it	  is 	  visible	  a 	  slight	  extracellular	  
staining	  which	  par7ally	  involved	  mineralized	  7ssue	  (Fig.	  31-­‐34).
Fig.31	  TNF-­‐α	  marking	  at	  T0,	  T1	  test	  group	  and	  T1	  control	  group.
Fig.32	  TNF-­‐α	  marking	  at	  200X	  total	  magniﬁca7on	  at	  T0.
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Fig.	  33	  TNF-­‐α	  marking	  at	  200X	  total	  magniﬁca7on	  at	  T1	  in	  test	  group.	  It	  is	  visible	  the	  
staining	  near	  and	  on	  gra@	  par7cles.





Were	  found	  sta7s7cally	  signiﬁcant	  diﬀerences 	  between	  	  TO	  and	  T1	  for	  BMP-­‐2,	  BMP-­‐7,	  IL-­‐6	  
and	  ALP	   (p<0.05)	   for	  both	  groups,	  but	   in	  the	  case	  of	  ALP	   the	  diﬀerence	  was	  nega7ve.	   It	  
was	  no7ced	  a 	  decrease	  of	  ALP	   values	  both	  for	   test	   and	  control.	   Regarding	  TNF-­‐α	  it	  was	  
found	  a	  sta7s7cally	   signiﬁcant	   increase 	  from	   T0	   to	  T1	   in	  test	   group	   (p<0.05),	  while 	  no	  
diﬀerences	  were	  observed	  in	  control	  group.
The	  test	   and	  control	  groups 	  were 	  also	   compared	  at	   T1	   for	   every	   marker;	   a 	  sta7s7cally	  
signiﬁcant	   diﬀerence	   was	   observed	   in	   BMP-­‐2	   (p<0.05)	   and	   TNF-­‐α	   (p<0.05),	   while 	   no	  
diﬀerences	  were	  found	  for	  other	  markers.
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7.	  Discussion
The	  histomorphometric	  analysis 	  reveals 	  a 	  high	  percentage	  of	  DBB	  par7cles 	  s7ll 	  remaining	  
in	  site 	  at	  5	  months,	  these	  data 	  are 	  in	  accordance 	  with	  literature 	  (Cordaro	  et	  al.	  2008)	  and	  
conﬁrm	   that	   the	   response	   obtained	   in	   our	   samples	   is	   comparable	   to	   other	   previous	  
studies 	  cited	  in 	  “ra7onale”	  paragraph.	  Despite	  the 	  high	  presence	  of	  DBB	  remained	  in	  site,	  
a 	  process	  of	  osteointegra7on	  was	  evident,	  new	  woven	  bone	  was 	  observed	  surrounding	  
gra@s,	   with	   bridge	   of	   newly	   formed	   bone	   between	   diﬀerent	   DBB	   par7cles.	   The	   high	  
presence	  of	   bone	  marrow	  surrounding	   gra@	   leads	  to	  understand	  that	   at	   5	   months 	  the	  
process	  of	  new	  bone 	  forma7on	  and	  osteointegra7on	  is 	  s7ll	  in 	  act	   in	  an	  early	  phase.	  This	  
concept	  is 	  strengthen	  by	  the	  diﬀerent	  results	  observed	  in	  the	  control 	  group.	  In	  the 	  control	  
group	  a	  higher	  presence	  of	  lamellar	  bone	  was	  found	  and	  this	  veriﬁca7on	  leads 	  to	  evaluate	  
the	  test	  group	  in	  a 	  slightly	  delayed	  bone 	  remodeling	  process.	  From	  a	  clinical	  point	  of	  view,	  
this 	   liale 	  delay	   is 	  balanced	   by	   several 	  clinical 	  advantages 	  related	  to	  DBB,	   in	  par7cular	  
space	   maintaining	   ability	   as 	   what	   described	   in	   cited	   literatures.	   Despite	   the	   smaller	  
presence	  of	   lamellar	   bone	  in	   test	   group,	   the 	  histomorphometric	   data 	  proved	  the	  good	  
osteointegra7on	   of	   gra@	   material 	   and	   the	   absence	   of	   nega7ve 	   reac7on	   or	   high	  
inﬂammatory	  response.
Shi@ing	   from	  histomorphometric	   data	  to	   immunohistochemistry,	  we	  will 	  analyze	  all 	  the	  
studied	  markers	  to	  beaer	   understand	  the	  eﬀect	   of	   DBB	   presence	  on	  bone	  remodeling	  
paaern.	  The	  observed	  data 	  are	  in	  accordance	  with	  literature 	  (Lalani 	  et	  al.,	  2003)	  and	  show	  
a 	  liale 	  increase	  in	  both	  bone	  morphogene7c	  proteins 	  from	  T0	  to	  T1	  in	  both	  groups.	  Lalani	  
observed	   in	   animal	   models,	   that	   in	   the 	   ﬁrst	   stages	   of	   healing	   BMP-­‐2	   were	   mainly	  
expressed	   in	   extracellular	   matrix	   of	   mesenchymal 	   cells,	   while	   in	   later	   phases,	   a@er	  
osteoblast	   migra7on	   and	   ac7va7on,	   they	   resulted	   expressed	   inside	   the 	   cells,	   and	   in	  
par7cular	   inside	  the 	  osteoblasts.	  We	  know,	  as 	  previously	   described	   in 	  the	   introduc7on,	  
that	   animal	  models	  may	   introduce	  bias,	   especially	   on	   the 	  7ming	   of	   bone	   remodeling	  
which	  is 	  accelerated.	  For	  this 	  reason	  we	  consider	  that	  the	  data 	  exposed	  by	   Lalani 	  et	   al.	  
may	   contribute	  to	  describe	  the	  contemporary	  presence	  of	  extracellular	   and	  intracellular	  
expression	  of	  BMP-­‐2	  at	  5	  months	  both	  in	  control	  and	  test	  group	  (Fig.35,36).	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Fig.35	  Intracellular	  BMP-­‐2	  marking	  at	  T1	  in	  test	  group	  at	  400x	  total	  magniﬁca7on.




The	  results 	  observed	  both	  in	  semiquan7ta7ve	  analysis	  and	  in	  qualita7ve	  evalua7on	  are	  in	  
according	  with	  Amerio	  et	  al.	  2010;	  we	  no7ced	  a 	  liale 	  increase 	  of	  BMP-­‐2	  marking	  in	  both	  
groups,	   but	  when	  comparing	  normalized	  diﬀerence	  between	  test	   and	  control 	  we	  found	  
less	  BMP-­‐2	  expression	  in	  test	  group	  (p<0.05).	   In	  our	  case	  we	  evaluated	  in	  vivo	  in	  human	  
BMP-­‐2	  expression,	  while	  Amerio	  et	  al.	   tested	  the 	  results 	  in	  an	  in	  vitro	  model 	  that	   is 	  not	  
able 	  to	  reproduce	  the	  complexity	   of	   the	  event	   taking	  part	   in	  bone	  remodeling	  process,	  
however	   the	  data 	  are 	  comparable.	   This 	  result	   anyway	   encourages 	  the 	  use	  of	   this 	  gra@	  
material 	  when	  it	  is	  necessary	  for	  clinical 	  reasons,	  thus 	  because 	  even	  we 	  found	  diﬀerences	  
between	  test	  and	  control,	  in	  both	  groups	  it	  was 	  found	  a	  qualita7ve	  increase	  between	  T0	  
and	  T1	  in	  BMP-­‐2	  expression.
BMP-­‐7	  expression	  follows 	  the	  same 	  increase 	  observed	  in	  BMP-­‐2,	  but	  it	  shows 	  a 	  diﬀerent	  
localiza7on.	  The	  increased	  expression	  is 	  in	  accordance	  with	  Trombelli 	  et	  al.	  (2008);	  in	  this	  
case	  the	  author	  performed	  an	  in	  vivo	  set	  up	  and	  for	  this	  reasons 	  we	  observed	  the	  same	  
results.	  The	  presence	  of	  the 	  gra@s,	  according	  to	  our	  results,	  is 	  not	  able 	  to	  induce	  a 	  higher	  
prolifera7on	  of	  BMP-­‐7	  than	  what	  observed	  in	  control	  group	  (+	  0.36%	  in	  test	  and	  +	  0.10%	  
in	  control),	  but	  the 	  same	  expression	  in	  both	  groups 	  conﬁrms 	  the	  eﬃcacy	  of	  this	  material	  
because	  it	  combines 	  clinical	  beneﬁts	  with	  the	  absence	  of	  nega7ve 	  eﬀect	  in	  term	  of	  bone	  
dynamics.	  
Regarding	   alkaline 	   phosphatase	   the	   observed	   results 	   are	   in	   countertrend	   with	   other	  
factors,	   in	   both	   groups	   it	   is 	   observed	   a	   decreasing	   in 	   expression	   value	   of	   the	  
semiquan7ta7ve	  analysis.	  These	  data 	  are	  in	  accordance	  with	  what	  expressed	  by	  Thurani	  
et	  al.	  (2005)	  who	  no7ced	  a	  decrease	  expression	  of	  ALP	  in	  osteoblast	  in	  contact	  with	  DBB.	  
Furthermore,	   as 	  what	  observed	  by	   Araújo	  et	  al.	   (2008),	  there 	  is	  a 	  liale 	  delay	   in	  alveolar	  
socket	   healed	   with	   the	   presence 	   of	   DBB,	   but,	   in	   these	   speciﬁc	   cases,	   the	   reduced	  
expression	  is	  observed	  also	  in	  control	  group.	  
IL-­‐6	  presented	  similar	   results 	  both	  in	  test	  and	  control	  group,	  it	  was 	  no7ced	  an	  increasing	  
in	   both	   cases 	  between	  T0	   and	   T1,	   with	  no	  diﬀerence	   between	   test	   and	   control 	  at	   5	  
months.	   This 	   results 	   explained	   clearly	   how	   at	   5	   months 	   a@er	   extrac7on	   the	   bone	  
remodeling	  process	  was	  in	  act,	  with	  remodeling	  cytokines 	  expression,	   s7mula7ng	  bone	  
resorp7on.
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Concerning	  TNF-­‐α	   the	  results	  are	  diﬀerent	   between	  test	   and	  control 	  group.	   In	  the	  test	  
group	  the	  marking	  of	  TNF-­‐α	  is 	  increased	  at	  5	  months,	  while	  in	  control 	  group	  the	  marking	  
remained	  the	  same	  from	  T0	  to	  T1,	  these	  results 	  are	  sta7s7cally	  signiﬁcant	  (p<0.05).	  These	  
data 	   underline	   the	   eﬀect	   of	   the	   biomaterial 	   on	   bone	   remodeling;	   the	   biomaterial 	   is	  
recognized	  by	  host	  cells	  as 	  a 	  material 	  that	  needs 	  to	  be 	  remodeled.	  For	  this 	  reason	  TNF-­‐α	  is	  
produced	  by	   macrophages 	  to	  s7mulate	  bone 	  resorp7on	  and	  ac7vates	  osteoclasts 	  cells,	  
while	  in 	  control 	  group	  host	  cells	  do	  not	  ac7vate	  this	  process 	  because	  there 	  is 	  no	  need	  to	  
absorb	  gra@s.	  Anyway,	  the	  presence 	  of	  TNF-­‐α	  is 	  limited	  also	  in	  test	  group	  conﬁrming	  the	  
ability	  of	  DBB	  of	  being	  well	  tolerated	  by	  the	  organism.
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8.	  Conclusions
These	  results 	  lead	  to	   aﬃrm	  that	  DBB	   is 	  able	  to	  maintain	  the	  ac7vity	   of	   all 	  remodeling	  
process.	   On	   the 	   other	   hand	   it	   brings	   to	   a	   lower	   expression	   of	   BMP2	   and	   a	   higher	  
expression	   of	   TNF-­‐α	   compared	   to	   what	   expressed	   in	   a	   similar	   model 	   healed	  
spontaneously.	  	  It	  is 	  the	  clinician	  who	  needs 	  to	  evaluate	  if	  the 	  reduc7on	  of	  BMP-­‐2	  and	  the	  
increasing	  of	  TNF-­‐α	  evaluated	  at	  5	  months,	  compared	  to	  control	  group,	  is	  balanced	  by	  the	  
clinical	  needs 	  for	  scaﬀold	  eﬀects 	  or	  not.	  When	  scaﬀold	  eﬀect	  is 	  required	  to	  maintain	  bone	  
dimension	  before 	  implant	   placement,	   and	   the 	  clinical 	  eﬃcacy	   of	   gra@s 	  for	   this 	  goal 	  is	  
proved	  by	   scien7ﬁc	   literature,	   as 	  in	   the	  case	   of	   DBB,	   the	  use	  of	   a 	  gra@	   is	   suggested.	  
Although	   we	   no7ced	   diﬀerences 	   at	   5	   months	   between	   test	   and	   control	   in	   BMP-­‐2	  
expression,	   in	  both	  groups 	  it	  was	  observed	  a 	  signiﬁcant	   increasing	  (p<0.05)	  between	  T0	  
and	   T1.	   These	   results 	   help	   us 	  to	   observe 	   that	   spontaneous 	   healing	   brings 	   to	   higher	  
expression	   of	   bone	   morphogene7c	   proteins 	   than	   what	   happens	   in	   alveolar	   socket	  
preserva7on	   with	   DBB,	   but	   in	   both	   cases 	   the 	   healing	   process 	   is 	  eﬃcient	   and	   this	   is	  
conﬁrmed	  by	  increasing	  in	  both	  groups	  of	  BMP	  expression	  from	  T0	  to	  T1.	  The	  reduc7on	  of	  
ALP	   expression	   from	   T0	   to	   T1	   is 	   observed	   in	   both	   groups	   and	   it	   was 	  not	   found	   any	  
diﬀerence	  at	  T1	  between	  the	  2	  groups.	  For	  this 	  reason	  it	  can	  be	  said	  that	  at	  5	  months 	  the	  
healing	  site	  is 	  not	   completely	  mature	  because	  new	  bone	  apposi7on	  is 	  required	  to	  have	  
complete 	  bone	  regenera7on	  and	  we 	  had	  conﬁrm	  of	   this 	  with	  the 	  posi7ve	  result	   found	  
with	   IL-­‐6	   in	   both	   groups.	   Nevertheless	   the	   quan7ty	   of	   the 	  bone	   seen	   at	   histological	  
analysis	  and	  found	  by	  clinicians,	  is 	  suﬃcient	  to	  correct	  implant	  placement	  and	  DBB	  seems	  
to	  not	  aﬀect,	  neither	  nega7vely	   or	  posi7vely,	   this 	  result.	  A	  diﬀerent	   situa7on	  was 	  found	  
for	  TNF-­‐α:	   in	  control 	  group	  it	  was 	  not	  found	  any	   increasing	  between	  T0	  and	  T1,	  while	  in	  
test	   group	  it	  was 	  found	  a 	  sta7s7cally	   signiﬁcant	   increasing	  at	  T1,	  with	  signiﬁcant	  results	  
for	  both	  tests 	  (T0	  vs	  T1	  p<0.05,	  T1	  test	  vs	  T1	  control 	  p<0.05).	   	   The	  higher	  expression	  of	  
TNF-­‐α	  is 	  jus7ﬁed	  by	  the 	  presence	  of	  the	  gra@s 	  that	  need	  to	  be 	  remodeled	  and	  subs7tuted	  
with	  new	  bone.	  Despite	  the	  limited	  number	  of	  the 	  cases 	  involved	  in	  this 	  study,	   it	   can	  be	  
aﬃrmed	   that	   DBB	   does 	   not	   inﬂuence	   nega7vely	   alveolar	   socket	   healing	   a@er	   tooth	  
extrac7on	  and,	   for	  this 	  reason,	  when	  a 	  gra@	   is 	  required	  for	   clinical 	  needs 	  it	  can	  be	  used	  
without	  any	  biologic	  nega7ve	  interac7on.	  Otherwise,	  when	  gra@	   is 	  not	  strictly	  useful 	  for	  
clinical	   beneﬁt,	   spontaneous	   healing	   is	   suggested	   because	   it	   promotes 	  more 	   BMP-­‐2	  
expression	  and	  leads	  to	  a	  lower	  TNF-­‐α	  produc7on.
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